A study on neurodevelopmental outcome of infants with hypoxic ischemic encephalopathyat government rajaji hospital madurai by Durga Devi, S
A STUDY ON NEURODEVELOPMENTAL OUTCOME OF 
INFANTS WITH HYPOXIC ISCHEMIC 
ENCEPHALOPATHYAT GOVERNMENT RAJAJI 
HOSPITAL MADURAI 
 
 
DISSERTATION SUBMITTED FOR THE DEGREE OF 
 
M.D BRANCH VII 
 
(PAEDIATRIC MEDICINE) 
 
MAY 2018 
 
 
 
 
 
                       
                   
 
THE TAMILNADU 
 
D.R M.G.R MEDICAL UNIVERSITY 
 
CHENNAI, TAMILNADU 
 
 
         
CERTIFICATE 
 
 
 
This is to certify that the dissertation entitled “A STUDY ON 
NEURODEVELOPMENTAL OUTCOME OF INFANTS WITH 
HYPOXIC ISCHEMIC ENCEPHALOPATHY” is the bonafide work 
of Dr. DURGA DEVI in partial fulfilment of the university regulations of 
the Tamil Nadu Dr. M.G.R Medical University, Chennai, for M.D Degree 
Branch VII – PAEDIATRIC MEDICINE examination to be held in May 
2018. 
 
 
 
 
Place: Madurai 
 
Date 
 
Dr.MARUDHUPANDIYAN  
M.S., FICS., FAIS., 
Dean, 
Madurai Medical College, 
Government Rajaji Hospital, 
Madurai-625020 
 
 
 
 
 
 
 
CERTIFICATE 
 
 
This is to certify that the dissertation entitled “A STUDY ON 
NEURODEVELOPMENTAL OUTCOME OF INFANTS WITH 
HYPOXIC ISCHEMIC ENCEPHALOPATHY” is the bonafide work 
of Dr.DURGA DEVI in partial fulfilment of the university regulations of 
the Tamil Nadu Dr. M.G.R Medical University, Chennai, for M.D Degree 
Branch VII – PAEDIATRIC MEDICINE examination to be held in May 
2018. 
 
 
Place: Madurai  
Date:         
         
 
PROF. Dr. K. MATHIARASAN M.D., D.C.H 
DIRECTOR 
Institute of Child Health & Research Center, 
Madurai Medical College, 
Madurai – 625020 
 
 
 
 
 
 
 
 
 
 
CERTIFICATE 
 
 
This is to certify that the dissertation entitled “A STUDY ON 
NEURODEVELOPMENTAL OUTCOME OF INFANTS WITH 
HYPOXIC ISCHEMIC ENCEPHALOPATHY” is the bonafide work 
of Dr. DURGA DEVI in partial fulfilment of the university regulations of 
the Tamil Nadu Dr. M.G.R Medical University, Chennai, for M.D Degree 
Branch VII – PAEDIATRIC MEDICINE examination to be held in May 
2018 
 
 
Place: Madurai  
Date: 
          
 
PROF. Dr.S.BALASANKAR M.D., D.C.H. 
PROFESSOR 
Institute of Child Health & Research Center, 
Madurai Medical College, 
Madurai-625020 
 
 
 
 
 
 
 
 
 
 
DECLARATION 
 
 
I, Dr. DURGA DEVI, solemnly declare that the dissertation titled                     
“A STUDY ON NEURODEVELOPMENTAL OUTCOME OF 
INFANTS WITH HYPOXIC ISCHEMIC ENCEPHALOPATHY” 
has been conducted by me at the Institute of Child Health and Research 
center, Madurai under the guidance and supervision of my unit Chief 
PROF. DR. S. BALASANKAR M.D., D.C.H. 
This is submitted in part of fulfilment of the award of the degree of 
M.D (Pediatrics) for the May 2017 examination to be held under the Tamil 
Nadu Dr. M.G.R Medical University, Chennai. This has not been 
submitted previously by me for any Degree or Diploma from any other 
University. 
 
 
PLACE: Madurai            
Date: 
 
Dr.DURGA DEVI S 
 
 
 
 
 
 
 
 
 
        
ACKNOWLEDGEMENT 
 
 
I sincerely thank Prof.Dr.Marudhupandiyan, the Dean, 
Government Rajaji Hospital and Madurai Medical College for permitting 
me to do this study. 
It gives me immense pleasure to express my sincere thanks and 
gratitude to Prof. Dr. K .Mathiarasan, M.D, D.C.H, Director & Professor 
of Pediatrics for his able guidance, encouragement, valuable suggestions 
and support for this study. 
I am greatly indebted to my chief Prof.Dr. S. Balasankar M.D, 
D.C.H, Professor of Pediatrics for his excellent guidance, able supervision, 
critical review, constant encouragement and full support rendered in every 
aspect of this study. 
I express my sincere thanks to Prof. Dr. Rajarajeshwaran,               
Prof.Dr.M.Kulandaivel, Prof.Dr.S.Shanmugasundaram,                     
Prof Dr.Nandhini kuppusamy, Prof.Dr.N.Balasubramaniyan,            
Prof. Dr.N. Muthukumaran, for their guidance and encouragement 
throughout the study. 
I would like to thank the Registrar Dr.D.Rajkumar M.D for his 
valuable suggestions throughout the study. 
I wish to express my sincere thanks to my guide and assistant  
professors Dr .J .Balasubramanian M.D, D.C.H, DAA , Dr. B. Vanitha  
M.D, and Dr. R. Suresh M.D, for their invaluable guidance, support and 
suggestions at every stage of this study. 
I also express my gratitude to all other assistant professors of our 
department and my fellow post graduates for their kind cooperation in 
carrying out this study. 
I also thank the members of the Ethical Committee, Government 
Rajaji Hospital and Madurai Medical College, Madurai for allowing me to 
do this study. 
I express my sincere thanks to my parents and my brother for their 
support throughout my study. 
Last but not the least, I submit my heartfelt thanks to the children 
and their parents for extending full co –operation to complete my study 
successfully. 
 
 
 
 
 
 
 
 
 
 
 
 
          
  
INDEX 
 
SL 
NO TITLE 
PAGE 
NO 
1 INTRODUCTION 1 
2 REVIEW OF LITERATURE 3 
3 AIMS AND OBJECTIVES 24 
4 METHODOLOGY 26 
5 RESULTS AND ANALYSIS 35 
6 DISCUSSION 76 
7 RECOMMENDATIONS 80 
8 LIMITATIONS 81 
 BIBLIOGRAPHY  
 PROFORMA  
 MASTER CHART  
 ABBREVIATIONS  
 
ETHICAL CLEARANCE 
CERTIFICATE  
 ANTI PLAGIARISM CERTIFICATE  
 
  
 
 
 
 
INTRODUCTION 
  
1 
 
INTRODUCTION 
                   
  Hypoxia refers to a decreased oxygenation to cells or organs. 
Ischemia refers to blood flow to cells or organs that is insufficient to 
maintain their normal function. 
Hypoxic–ischemic encephalopathy (HIE) is an important cause 
of permanent damage to CNS tissues that may result in neonatal death or 
manifest later as cerebral palsy or developmental delay. Approximately 
20-30% of infants with HIE die in the neonatal period, and 33-50% of 
survivors are left with permanent neurodevelopmental abnormalities 
(cerebral palsy, mental retardation). The greatest risk of adverse outcome 
is seen in infants with severe fetal acidosis (pH <6.7) (90% death / 
impairment) and a base deficit > 25 mmol/L (72% mortality). 
Neonatal encephalopathy is a clinical term that describes an 
abnormal neurobehavioral state consisting of decreased level of 
consciousness and usually other signs of brain stem and / or motor 
dysfunction.  
Hypoxic-ischemic encephalopathy is a term that describes    
encephalopathy with objective data to support a hypoxic-ischemic 
mechanism as the underlying cause for the encephalopathy. 
2 
 
The incidence of birth asphyxia is about 36.6 / 1000 live birth 
infants in Indian studies. According to World Health Organization 
(WHO), four to nine million cases of newborn asphyxia occur each year.  
In spite of significant advances in monitoring technology, obstetric 
care and knowledge of fetal and neonatal pathologies, asphyxia still 
remains a significant cause of mortality and long- term morbidity. More 
than a million newborns who survive asphyxia at birth develop long-term 
problems such as cerebral palsy, mental retardation, hearing, speech, 
visual and learning disabilities. 
An early intervention (EI) could improve neuro-developmental 
outcomes in survivors of birth asphyxia. Enrolment of high risk children 
and assessing their developmental status and planning for early 
intervention is of paramount importance. EI promotes child health, 
minimize developmental delays, cures existing disabilities, prevents 
functional deterioration, and promotes parent- child interaction. 
By thorough neurodevelopmental assessment and follow up of 
asphyxiated babies, neurodevelopmental abnormalities can be identified 
early and subject for early intervention, thus long term morbidity can be 
minimized. 
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REVIEW OF LITERATURE 
        
Ashaq et al[8] studied incidence  and neurodevelopmental outcome   
of HIE babies. They found out the incidence was 2.2 % in their hospital.   
Neurodevelopmental delay was present in 31.2% of babies at the end of 
one year in HIE patients. Also found out low apgar score at 5 minutes 
and low pH were predictors of poor neurodevelopmental outcome. 
Liliana et al studied factors associated with higher degree of 
severity in HIE and evaluate their outcomes. They found out that 
thompson score, abnormal aEEG at admission and at 48 hours, 
mechanical ventilation, acute renal failure, length of stay are associated 
with more severe HIE. They concludes that more severe HIE reflects 
worse outcomes and mild HIE is associated with normal outcome at 18 
months of age. 
Manxu et al [7] found out HIE infants with severe CT abnormality 
were associated with markedly lower psychomotor development when 
compared with normal infants and infants with mild CT abnormality. 
Hence Cranial  CT may be considered as reliable index to establish 
the prognosis of HIE. 
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Meena et al[6] found that early physiotherapy intervention 
improved the level of achievement of developmental domains in HIE 
infants. 
Charlene et al[5] suggested to focus on cognitive skills and 
language  development during assessment of 12 to 24 months of HIE 
survivors from their study. 
        Perez et al[4] found out children having HIE without major 
disability are increased risk   for long term intellectual verbal / motor  
deficits. Hence long term follow up are necessary for early detection of 
neurodevelopmental impairment and early initiation of adequate 
therapies. 
Samantha et al [3] studied vojta’s system of kinesiological 
diagnosis to identify infants at risk for neurodevelopmental delay as early 
as 3 months of age. 
Rabia G sezer[2] et al establish markers that can help in predicting 
prognosis of HIE infants with the help of cranial MRI and EEG. Cranial 
MRI has sensitivity and specificity of   83.3 % and 57.9 % respectively. 
EEG with normal or mildly abnormal correlated with favourable 
outcome and moderate or severely abnormal EEG correlated with poor 
outcome. 
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Caroline et al[1] estimated that 23 % of neonatal deaths worldwide 
can be attributed to asphyxia. Also found out that countries with high 
NMR, death rate is 8 times more that of   countries with low NMR.  
The World Health Organization has defined birth asphyxia as 
“failure to initiate and sustain breathing at birth” and based on Apgar 
score as an Apgar score of <7 at one minute of life. The National 
Neonatal Perinatal Database (NNPD) 2000, used a similar definition for 
perinatal asphyxia and defined moderate asphyxia as slow gasping 
breathing or an Apgar score of 4-6 and severe asphyxia as no breathing 
or an Apgar score of 0-3 at one minute of life. The National Neonatology 
Forum of India has defined asphyxia as “gasping or ineffective breathing 
or lack of breathing at one minute of life”. 
The essential criteria for diagnosing perinatal asphyxia as outlined by 
 ACOG & AAP are 
• Prolonged metabolic or mixed acidemia (pH <7.0 on cord arterial 
blood sample)  
• Persistence of an Apgar score of <3 for 5 min or longer  
• Clinical neurologic manifestation as seizures, hypotonia, coma or 
HIE in the immediate neonatal period  
• Evidence of multi-organ system dysfunction in the immediate 
neonatal period.  
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ETIOLOGY  
In term new-borns, asphyxia can occur in the antepartum or 
intrapartum period as a result of impaired gas exchange across the 
placenta that leads to the inadequate provision of oxygen (02) and 
removal of carbon dioxide (C02) and hydrogen (H+) from the fetus. 
Factors that increase the risk of perinatal asphyxia 
1. Impairment of maternal oxygenation 
2. Decreased blood flow from mother to placenta 
3. Decreased blood flow from placenta to fetus 
4. Impaired gas exchange across the placenta or at the fetal tissue 
Level 
5. Increased fetal 0 2 requirement. 
Etiologies of hypoxia-ischemia  
1. Maternal factors: hypertension (acute or chronic), hypotension,  
Infection (including chorioamnionitis), hypoxia from pulmonary or 
cardiac disorders, diabetes, maternal vascular disease, and inutero  
exposure to cocaine. 
2. Placental factors: abnormal placentation, abruption, infarction,  
fibrosis. 
3. Uterine rupture. 
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4. Umbilical cord accidents: prolapse, entanglement, true knot, 
compression. 
5. Abnormalities of umbilical vessels. 
6. Fetal factors: anemia, infection, cardiomyopathy, hydrops, severe 
cardiac / circulatory insufficiency. 
7. Neonatal factors: cyanotic congenital heart disease, persistent 
Pulmonary hypertension of the newborn (PPHN),  
cardiomyopathy, other forms of neonatal cardiogenic and / or  
septic shock. 
PATHOPHYSIOLOGY AND PATHOGENESIS 
With brief asphyxia, there is a transient increase, followed by a 
decrease in heart rate (HR), mild elevation in blood pressure (BP), an    
increase in central venous pressure (CVP), and essentially no change in 
cardiac output (CO). This is accompanied by a redistribution of CO with 
an increased proportion going to the brain, heart, and adrenal glands 
(diving reflex). This diversion of blood flow to vital deep nuclear 
structures of the brain does not occur, hence results in the typical pattern 
of injury to the subcortical and brain stem nuclei. 
With prolonged asphyxia, there can be a loss of pressure 
autoregulation   and / or C02 vasoreactivity. This, in turn, may lead to  
further disturbances in cerebral perfusion, particularly when there is  
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cardiovascular involvement with hypotension and / or decreased cardiac  
output. A decrease in cerebral blood flow results in anaerobic metabolism 
and eventual cellular energy failure due to increased glucose utilization in 
the brain and a fall in the concentration of   glycogen, phosphocreatine,  
and adenosine triphosphate (ATP). Prolonged asphyxia typically results 
in diffuse injury to both cortical and subcortical structures, with greater 
injury to neuronal populations particularly susceptible to HI insults. 
Cellular dysfunction occurs as a result of diminished oxidative 
phosphorylation and ATP production. This energy failure impairs ion 
pump function, causing accumulation of intracellular Na +, cl-, H 20, and 
Ca2+; extracellular K+; and excitatory neurotransmitters (e.g., 
glutamate).  
Impaired oxidative phosphorylation can occur during the primary 
HI insult(s) as well as during a secondary energy failure that usually 
occurs approximately 6 to 24 hours after the initiation of insult. Cell 
death can be either immediate or delayed, and either necrotic or 
apoptotic. 
Immediate neuronal death (necrosis) can occur due to 
intracellular osmotic overload of Na + and Ca2+, from ion pump failure 
as above or excitatory neurotransmitters acting on inotropic receptors 
(such as the N-methyl-D-aspartate (NMDA) receptor. 
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Delayed neuronal death (apoptosis) occurs secondary to 
uncontrolled activation of enzymes and second messenger systems within 
the cell (e.g.Ca2+dependent lipases, proteases, and caspases); 
perturbation of mitochondrial respiratory electron chain transport; 
generation of free radicals and leukotrienes; generation of nitric oxide 
(NO) through NO synthase; and depletion of energy stores. 
Reperfusion of previously ischemic tissue may cause further 
injury as it can promote the formation of excess reactive oxygen species 
(e.g., superoxide, hydrogen peroxide, hydroxyl, singlet oxygen), which 
can overwhelm the endogenous scavenger mechanisms, thereby causing 
damage to cellular lipids, proteins, and nucleic acids, as well as to the 
blood-brain barrier. This may result in an influx of neutrophils that, along 
with activated microglia, release injurious cytokines (e.g., interleukin 1 
and tumor necrosis factor α). 
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Topography of Brain Injury in Term Infants with HIE and Clinical 
Correlation 
AREA OF 
INJURY 
LOCATION OF 
INJURY 
CLINICAL 
CORRELATE(S)
LONG-TERM 
SEQUELA(E) 
Selective 
neuronal 
necrosis 
 
 
Entire neuraxis, 
deep cortical area, 
brainstem and 
pontosubicular 
Stupor or coma 
Seizures 
Hypotonia 
Oculomotor 
abnormalities 
Suck/swallow 
abnormalities 
Cognitive delay 
Cerebral palsy 
Dystonia 
Seizure disorder 
Ataxia 
Bulbar and 
pseudobulbar palsy 
Parasagittal 
injury 
 
 
Cortex and 
subcortical white 
matter 
Parasagittal 
regions, 
especially 
posterior 
Proximal limb 
weakness 
Upper extremities 
affected more 
than lower 
extremities 
Spastic 
quadriparesis 
Cognitive delay 
Visual and auditory 
processing 
difficulty 
Focal ischemic 
necrosis 
 
Cortex and 
subcortical white 
matter 
Vascular injury 
(usually middle 
cerebral artery 
distribution) 
Unilateral 
findings. 
Seizures common 
and typically focal 
 
Hemiparesis 
Seizures 
Cognitive delays 
Periventricular 
injury 
 
Injury to motor 
tracts, especially 
lower extremity 
 
Bilateral and 
symmetric 
weakness in 
lower extremities 
More common in 
preterm infants 
Spastic diplegia 
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NEUROLOGIC SIGNS  
The clinical spectrum of HIE is described as mild, moderate, or   
Severe by sarnat anad sarnat staging of HIE. 
SIGNS STAGE 1 (mild) 
STAGE 2 
(moderate) 
STAGE 3 
(severe) 
Level of consciousness Hyperalert Lethargic Stuporous, coma 
Muscle tone Normal Hypotonic Flaccid 
Posture Normal Flexion Decerebrate 
Tendon reflexes/clonus Hyperactive Hyperactive Absent 
Myoclonus Present Present Absent 
Moro reflex Strong Weak Absent 
Pupils Mydriasis Miosis Unequal, poor light reflex 
Seizures None Common Decerebration  
Electroencephalographic 
findings Normal 
Low voltage 
changing to 
seizure 
activity 
Burst 
suppression to 
isoelectric 
Duration 
<24 hr if 
progresses; 
otherwise, 
may remain 
normal 
24 hr-14 
days Days to weeks 
Outcome Good Variable Death, severe deficits 
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Encephalopathy 
Newborns with HIE must have depressed consciousness by 
definition, whether mild, moderate, or severe. Mild encephalopathy can 
consist of an apparent hyperalert or jittery state, but the newborn does not 
respond appropriately to stimuli, and thus consciousness is abnormal. 
Moderate and severe encephalopathies are characterized by more 
impaired responses to stimuli such as light, touch, or even noxious 
stimuli. The background pattern detected by EEG or aEEG is useful for 
determining the severity of encephalopathy. 
 Brain stem and cranial nerve abnormalities 
Newborns with HIE may have brain stem dysfunction, which may 
manifest as abnormal or absent brain stem reflexes, including  pupillary, 
corneal, oculocephalic, cough, and gag reflexes. There can be abnormal 
eye movements such as dysconjugate gaze, gaze preference, ocular 
bobbing or other abnormal patterns of bilateral eye movements, and an 
absence of visual fixation or blink to light. Newborns may show facial 
weakness (usually symmetric) and have a weak or absent suck and 
swallow with poor feeding. They can have apnea or abnormal respiratory 
patterns. 
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Motor abnormalities 
With greater severity of encephalopathy, there is generally greater 
hypotonia, weakness, and abnormal posture with lack of flexor tone, 
which is usually symmetric. With severe HIE, primitive reflexes such as 
the Moro or grasp reflex may be diminished. Over days to weeks, the 
initial hypotonia may evolve into spasticity and hyperreflexia if there is 
significant HI brain injury. Note that if a newborn shows significant 
hypertonia within the first day or so after birth, the HI insult may have 
occurred earlier in the antepartum and have already resulted in 
established HI brain injury. 
Seizures occur in up to 50% of newborns with HIE, and usually 
start within 24 hours after the HI insult. Seizures indicate that the severity 
of encephalopathy is moderate or severe, not mild. Seizures may be 
subtle, tonic, or clonic. It can sometimes be difficult to differentiate 
seizures from jitteriness or clonus, although the latter two are usually 
suppressible with firm hold of the affected limb(s). Since seizures are 
often subclinical (electrographic only) and abnormal movements or 
posture may not be seizure, EEG remains the gold standard for 
diagnosing neonatal seizures, particularly in HIE. Seizures may 
compromise ventilation and oxygenation, those who are not receiving 
mechanical ventilation. 
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      Increased intracranial pressure (ICP) resulting from diffuse 
cerebral edema in HIE often reflects extensive cerebral necrosis rather   
than swelling of intact cells and indicates a poor prognosis. Treatment to 
reduce ICP does not affect outcome.  
MULTIORGAN DYSFUNCTION 
         Other organ systems in addition to the brain usually exhibit 
evidence of asphyxial damage. In a minority of cases (<15%), the brain 
may be the only organ exhibiting dysfunction following asphyxia. The 
kidney is the most common organ to be affected in the   setting of 
perinatal asphyxia. The proximal tubule of the kidney is specially 
affected by decreased perfusion, leading to acute tubular necrosis   with 
oliguria. 
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MULTIORGAN SYSTEMIC EFFECTS OF ASPHYXIA 
 
 
 
SYSTEMS EFFECT (S) 
CNS 
HIE, infarction, intracranial 
hemorrhage, seizures, 
cerebral edema, hypotonia, hypertonia 
Cardiovascular 
Myocardial ischemia, poor contractility, 
cardiac stunning, tricuspid insufficiency, 
hypotension 
Pulmonary Pulmonary hypertension, pulmonary hemorrhage, RDS 
Renal Acute tubular or cortical necrosis 
Adrenal Adrenal hemorrhage 
Gastrointestinal Perforation, ulceration with hemorrhage, necrosis 
Metabolic 
Inappropriate secretion of antidiuretic 
hormone, hyponatremia, hypoglycemia, 
hypocalcemia, myoglobinuria. 
Integument Subcutaneous fat necrosis 
Hematology Disseminated intravascular coagulation 
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LABORATORY EVALUATION OF ASPHYXIA 
 
Cardiac evaluation  
Cardiac troponin I (cTNI) and cardiac troponin T (cTnT), cardiac 
regulatory Proteins that control the calcium-mediated interaction of actin 
and myosin, are markers of myocardial damage. Normal values in the 
neonate are troponin I = 0 to 0.28 +/_ 0.42 JJ.μg/L and troponin T = 0 to 
0.097 μg/L. Elevated levels of these proteins have been described in 
newborns with clinical and laboratory evidence of asphyxia. 
         An elevation of serum creatine kinase myocardial bound (CK-MB) 
fraction of >5% to 10% may indicate myocardial injury. 
Neurologic markers of brain injury  
Serum CK-BB may be increased in asphyxiated newborns within 
12 hours of   the insult, but has not been correlated with long-term   
neurodevelopmental outcome. CK-BB is also expressed in placenta, 
lungs, gastrointestinal tract, and kidneys. Other serum markers such as 
protein S-100, neuron specific enolase, and urine markers have been 
measured in newborns with asphyxia and HIE. 
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Renal evaluation  
Blood urea nitrogen (BUN) and serum creatinine (Cr) may be 
elevated in perinatal asphyxia. Typically, elevation is noted 2 to 4 days 
after the insult. Fractional excretion (FE) of Na+ or renal failure index 
may help confirm renal insult. Urine levels of β2-microglobulin have 
been used as an indicator of proximal tubular dysfunction, although not 
routinely. This low molecular weight protein is freely filtered through the 
glomerulus and reabsorbed almost completely in the proximal tubule. 
Renal sonographic abnormalities correlate with the occurrence of 
oliguria. 
BRAIN IMAGING 
Cranial sonographic examination can demonstrate edema as loss of 
gray-white differentiation when severe, but is generally insensitive for 
the detection of HI brain injury, particularly in the first days after birth. It 
may be useful to rule out large intracranial hemorrhage, particularly since 
this may be a contraindication to therapeutic hypothermia. 
Computed tomography (CT) may be used to detect cerebral edema, 
hemorrhage, and eventually HI brain injury. Because of the degree of    
radiation exposure, CT is only indicated if imaging is urgently needed to 
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determine clinical treatment and neither ultrasound nor MRI is available 
on an emergency basis. 
Magnetic resonance imaging (MRI) Conventional T1- and T2-
weighted MRI sequences are the best modality for determining the 
severity and extent of HI brain injury, but the injury is often not apparent 
on these sequences in the first days after the HI insult (unless the injury is 
older than suspected or very severe).These conventional sequences are 
best for the detection of brain injury after 7 to 10 days, and a scan as late 
as 14 days or older may be needed if there are clinical signs of HI brain 
injury without imaging correlates at an earlier time. 
1. Diffusion-weighted imaging (DWI) can show abnormalities within 
hours of an HI insult that may be useful in the diagnosis of 
neonatal HIE and an early indicator of possible brain injury. 
However, DWI can both underestimate and overestimate the 
location and severity of HI brain injury, depending on the timing of 
the study. Early DWI scans will usually show restricted diffusion 
in brain regions affected   by hypoxia-ischemia, although this does 
not inevitably mean that these regions are irreversibly injured. At 7 
to 10 days of age, there is pseudonormalization of diffusion, so 
DWI can appear normal despite the presence of HI injury. After 7 
to 10 days, diffusion is usually increased in regions of HI brain 
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injury. Thus, DWI data need to be interpreted carefully within the 
context of the history and clinical course of the newborn with HIE. 
2. Proton magnetic resonance specttoscopy (MRS), also called 
proton-MRS Or 1 H-MRS, measures the relative concentrations of 
various metabolites in tissue. Elevated lactate, decreased                    
N-acetylaspartate (NAA), and alterations of the ratios of these two 
metabolites in relation to choline or creatine can indicate HIE and 
help prognosticate neurologic outcome. 
3. Susceptibility-weighted imaging may be useful for the detection of 
hemorrhage or hemorrhagic injury. 
4. MR angiography or venography may occasionally be useful if 
there is suspicion of vascular anomalies, thromboembolic disease, 
or sinus venous thrombosis resulting in HI injury. 
EEG is used both to detect and monitor seizure activity and also to 
define abnormal background patterns such as discontinuous burst 
suppression, low voltage, or isodectric patterns. When conventional 8- or 
16-channd neonatal EEG is not readily available, amplitude-integrated 
EEG (aEEG) has been used to evaluate the background pattern, 
particularly when rapid assessment is needed for determination of   
treatment with therapeutic hypothermia. This method consists of a 
reduced montage with 1- or 2-channel EEG with parietal electrodes. 
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Although aEEG may detect some seizures, there are data showing that 
aEEG is insufficient to detect all seizures compared with conventional 
EEG, and that the quality of aEEG interpretation depends very much on 
the experience and expertise of the reader. 
Developmental Therapy 
Therapy Based on Passive Exercises 
          Out of the items assessed in the Amiel-Tison method, the angles 
give an important clue for the therapy and stimulation part of 
intervention. A limitation in angles indicates hypertonia and wide angle 
indicates hypotonia in most cases. In such instances, stimulation becomes 
effective only after normalizing the muscle tone. The purpose of passive 
therapy is essentially to reduce these deformities by constant effort of the 
mother in a playful manner. Home therapy based on Amiel-Tison passive 
angles is a simple concept which does not aim to hasten developmental 
milestones, but aims to prevent 
• Mental subnormality by better mother-infant interaction 
• Joint stiffening by repeated passive movements 
• Contractures by repetitive passive movements 
• Muscle wasting and fibrosis 
• Helplessness in parents. 
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Therapy Based on Motor Milestones  
Head Holding/Neck Control 
• Stimulating the child to hold the head by carrying the child in an 
upright position by supporting the infant’s head as and when 
possible. 
• While playing and talking with the child, lift the child by 
supporting his upper arm and chest, thereby stimulating him to lift 
and hold his head. 
• The child must be made to lie on his stomach and is guided on his 
elbow (a roll or round pillow can be used if necessary). Encourage 
the child to lift and hold his head by showing a colourful toy. 
• Stimulate the child in prone position guiding on his hand on the 
surface, encourage the child to lift and hold his head and then 
rotate laterally showing a colorful toy. 
Sitting 
• Encourage the child to sit by putting him in an arm chair in a 
sitting position supporting him with pillows, as and when possible. 
• While playing and talking with the child, encourage the child in 
sitting position with a wide base (thighs apart), supporting at the 
pelvis with a downward force. 
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• During play, the child can be encouraged in side-sitting position on  
both sides by supporting himself on the hand to the side which he 
is sitting. 
• Guide the child to support on his hand and knees (four point 
kneeling / quadruped position) during play. A roll or pillow can be 
used if necessary. Then slowly guide him to sit on one of his sides 
supported by the same hand. Help the child to maintain this 
position for a while. 
• Then guide him again on to his hands and knees and then gradually 
to side sitting on the other side. 
• Baby walker can also be used to stimulate and improve sitting. 
Standing 
• Guide the child on to his both knees during play. Finally support 
him at the pelvis. If necessary, give support to the upper part of his    
body. Gradually the support can be withdrawn and the child can be  
made to support himself by holding on to a low stool. This position 
can be maintained by directing the child’s attention to any play 
activity. 
• From lying on the back position (supine position), stimulate the    
child to sit and gradually to the standing position during play time. 
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• Firstly, guide the child to his both knees supporting himself on a 
low stool with both hands. While directing his attention to a 
colourful toy through play, slowly help him to raise one leg so as 
to make him stand on one foot (leg straight), the other on the knee 
(half standing position) help the child to maintain this position 
while playing and talking with him. This position can be repeated 
on other side. Meanwhile depending on the child’s ability, 
stimulate him to pull to standing position by himself, supporting on 
the stool. 
• Encourage the child in standing position as and when possible, first 
with support then gradually withdrawing the support as per the 
child’s ability. A baby walker will also severe the purpose of 
developing standing and walking skills. 
 
 
 
     
  
 
 
 
 
 
 
AIMS AND OBJECTIVE 
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AIMS OF STUDY 
• To assess the neurodevelopmental outcome of infants with 
Hypoxic Ischemic Encephalopathy. 
• To assess the relationship between severity of Hypoxic  
Ischemic Encephalopathy and neurodevelopmental outcome. 
• To assess the neurodevelopmental outcome by DDST (Denver 
Developmental screening test) as screening tool and DASII 
(Development Assessment Scale for Indian Infants) as 
confirmatory. 
SAMPLE SIZE : 150 infants 
STUDY DESIGN :   Hospital based Prospective analytical study 
STUDY PERIOD : March 2016 - August 2017 
STUDY POPULATION  
Inclusion criteria : infants completed 37 weeks of gestation  
         - For inborn babies, Apgar score < 6 at 5 min   or 
         - For outborn babies, history of asphyxia  
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1. h/o   delayed   first cry more than 5 minutes or 
2. Need for positive pressure ventilation more than 1 minute.  
Showing clinical signs of HIE as per sarnat   and sarnat   staging   will be 
included. 
Exclusion criteria  
• Infants with Gestational age < 37 weeks, 
• Perinatal infection, 
• Congenital anomalies, 
• Suspected metabolic disorders, 
• Infants not been followed upto 1 year 
 
             
  
  
 
 
 
 
 
 
MATERIALS AND 
METHODS 
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MATERIALS AND METHODOLOGY  
 
               After taking the informed written consent from the parent or 
guardian, the relevant information regarding pregnancy, delivery and 
neonatal period will be collected from the parents and neonatal records 
and recorded in a predesigned proforma. At enrollment detailed history 
and neurological examination will be done to detect neurological deficits 
and tone abnormalities. All   infants with HIE   will be screened in OPD   
at 3, 6, 9 and 12 months of age. 
At each follow up they will be undergoing 
1. Neurological examination using Amiel-Tison scoring at 3, 6, 9 and 
12   months of age. 
2. Neurodevelopmental assessment using DDST as screening tool at 
3, 6, 9, 12 months and DASII as confirmatory test at the end of 1 
yr and at any age for those who are found to be abnormal in using 
DDST. 
3. Growth assessment (detailed anthropometry) and developmental 
milestones. 
3. Nutrition Assessment (Breastfeeding or weaning) 
4. Hearing assessment using OAE as screening test and Brainstem 
Evoked Response Audiometry(BERA) if warranted. 
5. Vision assessment at first visit and subsequently VEP if warranted. 
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Neurological Evaluation 
       Amiel-Tison   has   provided   us   with a   comprehensive   system   
of neurological   evaluation   for   the first   year of life that gives us a 
framework for instituting physical therapy program. In the Amiel-Tison 
method of neurological evaluation presence of hypotonia is identifiedby 
measuring the following angles. 
Adductor Angle: With the infant lying supine, the legs are 
extended and gently pulled as far apart as possible. The angle formed by 
the legs at this point is called the adductor angle. Asymmetry between the 
right and the left leg should be noted. 
Heel to Ear: With the infant lying supine, the legs are held together 
and pressed as far as possible, towards the ear. The pelvis must not be 
lifted from the table. The angle is represented by the arc extending from 
the infant’s heel to the table. Increased resistance on one side is an 
indication of asymmetry, but it might be difficult to apply equal pressure 
to both sides. 
Popliteal Angle : The thighs are flexed laterally at the hip along 
both  Sides of   the abdomen. While holding the infant in this position, 
the examiner presses the lower leg as far as possible towards the thigh. 
The popliteal angle, which is formed by the calf and the thigh, is 
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estimated in both legs simultaneously. It is easier to apply equal pressure 
to both sides when examining the popliteal angle. Therefore, the 
estimation of asymmetry is more objective. Significant asymmetry is 
indicated by a difference of 10–20° between the right and left angles.  
Dorsiflexion Angle of the Foot: The examiner holds the infant’s 
leg straight and flexes the foot toward the leg. This is accomplished by 
applying pressure with the thumb to the sole of the foot. The dorsiflexion 
angle is formed by the dorsum of the foot and the anterior aspect of the 
leg. 
Scarf Sign: The infant is held in a semi-reclining position, 
supported by the examiner’s palm. At the same time, the examiner takes 
the infant’s hand and pulls the arm as far as possible, across the chest 
towards the opposite shoulder. Four positions are possible in describing 
the position of the elbow in relationship to the umbilicus. 
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FIGURE SHOWING AMIEL TISON ANGLES 
NEUROLOGICAL ASSESSMENT BY AMIEL TISON ANGLES 
Age(month)
Adductor 
angle 
Popliteal 
angle 
Dorsiflexion 
angle 
Scarf sign 
0-3 40-80 80-100 60-70 
Elbow not cross 
midline 
4-6 70-120 90-120 ” Crosses midline 
7-9 110-140 110-160 ” 
Goes beyond 
axillary line 
10-12 140-160 150-170 ”  
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         While doing DDST II the items intersected by and just adjacent to 
the age line will be tested. The items will be denoted as P for pass, F for 
failed, No for no opportunity, and R for refused to cooperate or attempt. 
The interpretation of the individual items will be made as   follows: 
a. Advanced : Child passes item that falls completely to the right of 
the age line. 
b. Normal: Child fails or refuses an item that falls completely to the 
right of the age line / Child passes, fails, or   refuses item on which 
the age line falls between the 25 th and 75 th percentile 
c. Caution: Child fails or refuses item on which the age line falls 
between the 75 th and 90 th percentile. 
d. Delayed: Child fails or refuses item that falls completely to the left 
of the age line. 
e. No opportunity: Child has had no chance to perform the item 
(taken only for report items). 
DDST II test overall interpretation will be done as 
i. Normal: Child with no delays and a maximum of 1 caution. 
ii. Suspect: Two or more cautions and /or one or more delays. 
iii. Untestable: Refusal scores on 1 or more items completely to the 
left of age line or; more than one item intersected by the age line in the 
75-90 th percentile area. These children will be rescreened again. 
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Infants with a normal neurological examination and normal DDST 
II   will be considered as having normal neurodevelopmental outcome 
and those who have an abnormal neurological examination by DDST II   
will undergo DASII for further assessment. Those who   has been 
untestable by DDST II will be reassessed after 2 weeks. 
DEVELOPMENTAL ASSESSMENT SCALE FOR INDIAN 
INFANTS (DASII) 
This is the gold standard   test used   for developmental evaluation, 
developed by Pramila   Phatak,   and is based on Bayley Scales of   Infant 
Development (BSID). Both mental development index and 
psychomotor development index can be calculated by DASII. The age 
placement of the item at the total score   of the scale is noted as the 
child’s developmental age. This gives child’s   total scores to his motor 
age (MoA) and mental age (MeA). The respective ages are used to 
calculate his motor and mental development quotients respectively by 
comparing them with his chronological age and multiplying it by 100. 
(DMoQ = MoA/CA x 100 and DMeQ = MeA/CA x 100).  
The composite development quotient (DQ) is derived as an 
average of DMoQ and DMeQ.  
The test needs a special kit and cooperation of the child. 
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        At 12 months of age all the babies will be assessed using 
Developmental Assessment Scales for Indian Infants (DASII). Abnormal 
neurodevelopmental outcome will be diagnosed if any one of the 
following abnormalities are to be identified- 
1.MoQ or MeQ of less than 70% on DASII. 
2.Hearing Loss. 
3.Visual Impairment.  
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STATISTICAL ANALYSIS 
The information collected regarding all the selected cases were 
recorded in a Master Chart. Data analysis was done with the help of 
computer using” SPSS v16 software. Using this software range, 
frequencies, percentages, means, standard   deviations, chi square and p 
values were calculated. 
Kruskul Wallis chi square test was used to test the significance of   
difference between quantitative variables. A p value less than 0.05 is 
taken to denote significant relationship. 
  
 
 
 
 
 
 
RESULTS AND ANALYSIS 
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RESULTS AND ANALYSIS 
 
Totally 150 infants were studied during the study period. 
PROFILE OF STUDY PARTICIPANTS 
TABLE 1 – GENDER DISTRIBUTION OF STUDY POPULATION 
GENDER N % 
Male 98 65.3% 
Female 52 34.6% 
 
Out of 150 infants, 98(65.3%) were male and 52 (34.6%) were female 
infants. 
 
65.30%
34.60%
FIGURE 1 -GENDER  DISTRIBUTION OF STUDY 
POPULATION
HIE I
HIE II
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TABLE 2 -   SEVERITY OF HIE - GENDERWISE 
Variable 
N (%) 
Diagnosis 
HIE I 
38 (25.3) 
HIE II 
95 (63.3) 
HIE III 
17 (11.3) 
Sex 
Male 98 (65.3) 23 (60.5) 68 (71.6) 7 (41.2) 
Female 52 (34.6) 15(39.5) 27 (28.4) 10 (58.8) 
 
Out of the 150 cases,38 (25.3 %) had HIE I, 95(63.3 %) had   HIE 
II and 17(11.3%) cases had   HIE III. Out of the 150 cases, 98 (65.3%) 
cases were males and 52 (34.6%) cases were females. 
Out of the 38 HIE I cases, 23 (60.5 %) cases were males and 15 
(39.5 %) cases were females.  
Out of the 95 HIE II cases, 68 (71.6 %) cases were males and 27 
(28.4%) cases were females. 
Out of the 17 HIE III cases, 7 (41.2 %) cases were males and 10 
(58.8 %) cases were females. 
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25.30%
63.30%
11.30%
FIGURE 2-CASE DISTRIBUTION OF STAGES OF 
HIE IN STUDY POPULATION
HIE I
HIE II
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FIGURE 3 : SEVERITY OF HIE GENDERWISE 
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TABLE 3 – CASE DISTRIBUTION IN ALL STAGES OF HIE 
BASED ON ORDER OF BIRTH 
Variable 
N (%) 
Diagnosis 
HIE I HIE II HIE III 
 
Primi 100(66.6) 30 (78.9) 60 (63.2) 10 (58.8) 
Multigravida 50(33.3) 8 (21.1) 35 (36.8) 7 (41.2) 
 
Out of 150 HIE cases, 100 (66.6%) cases were delivered by primi 
gravida mothers and 50 (33.3%) cases were delivered by multigravida 
mothers. 
Out of 38 HIE I cases, 30 (78.9%) cases were delivered by primi 
gravida  mothers and 8 ( 21.1%) cases were delivered by multi gravida 
mothers. 
Out of 95 HIE II cases, 60 (63.2 %) cases were delivered by primi 
gravida mothers and 35 ( 36.8%) cases were delivered by multi gravida 
mothers. 
Out of 17 HIE III cases, 10 (58.8%) cases were delivered by primi 
gravida mothers and 8 ( 41.2%)   cases were delivered by multi gravida 
mothers. 
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FIGURE 4 - CASE DISTRIBUTION IN ALL STAGES OF HIE 
BASED ON ORDER OF BIRTH 
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TABLE 4- CASE DISTRIBUTION IN ALL STAGES OF HIE 
BASED ON ANTENATAL RISK FACTORS 
Variable 
N (%) 
Diagnosis 
HIE 1 HIE 2 HIE 3 
Antenatal 
risk 
No risk 92(61.3) 16(42.1) 62(65.3) 14(82.4) 
GDM 10(6.6) 5(13.2) 4 (4.2) 1(5.9) 
MAS 42(28) 14(36.8) 27(28.4) 1(5.9) 
PIH 6(4) 3(7.9) 2(2.1) 1(5.9) 
 
Out of 150 HIE cases, 92(61.3%) had no antenatal risk factors. 
Other 58 cases had antenatal risk factors. Among them GDM 10 cases 
(6.6%), MAS 42 cases (28%), PIH 6 cases (4%). 
Out of 38 HIE I cases,16 (42.1%) had no antenatal risk factors. 
Other 22 cases   had antenatal risk factors. Among them GDM 5 
cases(13.2%),  MAS   14 cases (36.8 %), PIH   3 cases (7.9%). 
Out of 95 HIE II cases,62 (65.3%) had no antenatal risk factors. 
Other 33 cases   had antenatal risk factors. Among them GDM 4 
cases(4.2%), MAS 27 cases (28.4 %), PIH   2 cases (2.1%). 
Out of 17 HIE III cases,14 (82.4%) had no antenatal risk factors. 
Other 3 cases   had antenatal risk factors. Among them GDM 1 case(5.9 
%),  MAS 1 case (5.9 %), PIH   1 case (5.9%). 
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FIGURE 5- CASE DISTRIBUTION OF ALL STAGES OF HIE 
BASED ON ANTENATAL RISK FACTORS 
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TABLE 5- CASE DISTRIBUTION OF ALL STAGES OF HIE 
BASED ON PLACE OF DELIVERY 
Variable 
N(%) 
Diagnosis 
HIE I HIE II HIE III 
O/I 
Inborn 81( 54) 31(81.6) 48 (50.5) 2 (11.8) 
Outborn 69 ( 46) 7 (18.4) 47 (49.5) 15 (88.2) 
 
Out of 150 HIE cases, 81 (54%) cases were inborn and 69 (46%) 
cases were outborn. 
Out of 38 HIE I cases, 31 (81.6%) cases were inborn and 7 
(18.4%) cases were outborn.  
Out of 95 HIE II cases, 48 (50.5%) cases were inborn and 47 (49.5 
%) cases were outborn.  
Out of 17 HIE III cases, 2 (11.8%) cases were inborn and 15 
(88.2%) cases were outborn.  
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FIGURE 6 – CASE DISTRIBUTION OF ALL STAGES OF HIE 
BASED ON PLACE OF DELIVERY 
 
 
 
 
 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
HIE 1 HIE 2 HIE 3
diagnosis
82%
51%
12%
18%
50%
88%
%
 O
f C
ase
s
O/L
Inborn
Outborn
45 
 
TABLE 5 - CASE DISTRIBUTION OF ALL STAGES OF HIE 
BASED ON MODE OF DELIVERY 
Variable 
N(%) 
Diagnosis 
HIE I HIE II HIE III
Mode of 
delivery 
Normal 111(74) 25 (65.8) 72(75.8) 14(82.4)
AVD 9 (6) 2(5.3) 4(4.2) 3(17.6) 
LSCS 30(20) 11(28.9) 19(20) 0 (0) 
 
Out of 150 total HIE cases, 111 (74%) cases were delivered by 
normal delivery, 9(6%) cases were delivered by AVD,30 (20%) cases 
were delivered by LSCS. 
Out of 38 HIE I cases, 25 (65.8%) cases were delivered by normal 
delivery, 2 (5.3%) cases were delivered by AVD ( assisted vaginal  
delivery),11 (28.9%) cases were delivered by LSCS 
Out of 95 HIE II cases, 72 (75.8%) cases were delivered by normal 
delivery, 4 (4.2%) cases were delivered by assisted vaginal delivery,19 
(20%) cases were delivered by LSCS. 
Out of 17 HIE III cases, 14 (82.4 %) cases were delivered by 
normal delivery, 3 (17.6%) cases were delivered by assisted vaginal 
delivery. 
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FIGURE 7- CASE DISTRIBUTION OF ALL STAGES OF HIE 
BASED ON MODE OF DELIVERY 
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TABLE 7- CASE DISTRIBUTION IN ALL STAGES OF HIE 
BASED ON TYPES OF RESUSCITATION 
Variable 
N (%) 
Diagnosis 
HIE 1 HIE 2 HIE 3 
Resuscitation
No resuscitation 7(4.6) 1(2.6) 6(6.3) 0 (0) 
Tactile stimulation 25(16.6) 8 (21.1) 16(16.8) 1(5.9) 
Bag and Mask 
ventilation(BMV)
105(70) 25(65.8) 70(73.7) 10(58.8) 
Intubation 13(8.6) 4(10.5) 3(3.2) 6(35.3) 
 
Out of   150 total HIE cases, 7 cases(4.6%) needed no 
resuscitation, 25 cases (16.6%) needed tactile stimulation, 105 cases 
(70%) needed BMV, 13 cases (8.6%) needed intubation. 
Out of 38 HIE I cases, 1 case (2.6%)needed no resuscitation, 8 
cases (21.1%)   needed tactile stimulation, 25 cases ( 65.8%) needed 
BMV, 4 cases (10.5%) needed intubation . 
Out of 95 HIE II cases, 6 cases (6.3%) needed no resuscitation, , 
16 cases  (16.8%) needed   tactile stimulation, 70 cases (73.7%) needed 
BMV, 3  cases (3.2%) needed   intubation . 
Out of 17 HIE III cases, 1 case (5.9%) needed tactile   stimulation, 
10 cases (58.8%) needed   BMV, 6 cases (35.3%) needed intubation. 
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FIGURE 8 - CASE DISTRIBUTION IN ALL STAGES OF HIE 
BASED ON TYPES OF RESUCITATION 
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TABLE 8 – COMPLICATIONS OF HIE IN ALL STAGES 
 
Variable 
N(%) 
Diagnosis 
HIE 1 
(n-38) 
HIE 2 
(n-95) 
HIE 3 
(n-17) 
NNC 
Yes 107(71.3) 0 (0) 94(98.9) 13(76.5) 
No 43(28.6) 38(100) 1(1.1) 4(23.5) 
Ventilation 
Yes 38(25.3) 2 (5.3) 20(21.1) 16(94.1) 
No 112(74.6) 36(94.7) 75(78.9) 1(5.9) 
Shock 
Yes 16(10.6) 0(0) 2(2.1) 14(82.4) 
No 134(89.3) 38(100) 93(97.9) 3(17.6) 
multi organ 
injury 
Yes 15(10) 0(0) 3(3.2) 12(70.6) 
No 135(90) 38(100) 92(96.8) 5(29.4) 
Sepsis 
Yes 61(40.6) 11(28.9) 37(38.9) 13(76.5) 
No 89(59.3) 27(71.1) 58(61.1) 4(23.5) 
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Out of 150 total HIE cases,107 cases (71.3%) went in for neonatal 
convulsions, 38 cases (25.3%) needed ventilation, 16 cases (10.6%)   
went in for shock, 15 cases (10%) had multi organ injury, 61 cases 
(40.6%) had sepsis. 
Out of 38 HIE I cases, 2(5.3 %) cases need ventilator support, 11 
(28.9%) cases had sepsis. All HIE I cases not went in for convulsions, 
shock, multi organ injury. 
Out of 95 HIE II cases, 94 (98.9%) cases went in for convulsions, 
20(21.1%) cases need ventilator support, 2 (2.1%) cases went in for 
shock, 3(3.2%) cases had multi organ injury,37 (38.9%) cases had sepsis. 
Out of 17 HIE III cases, 13 (76.5%) cases had convulsion, 16 cases 
(94.1%)   need ventilator support, 14 (82.4%) cases went in for shock, 12 
(70.6%) cases had multi organ dysfunction, 13 cases (76.5%) cases had 
sepsis. 
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TABLE 9 – ASSOCIATION BETWEEN LENGTH OF INFANTS 
AND STAGES OF HIE 
Variable Diagnosis N Mean SD p value 
Length(cm) 
HIE I 38 49 2.4  
0.276 
 
HIE II 95 49 2.2 
HIE III 17 48 3.1 
 
Among the 38 HIE I cases, mean value of length is 49 cm with 
standard deviation of 2.4. 
Among the 95 HIE II cases, mean value of length is 49 cm with 
standard   deviation of 2.2. 
Among the 17 HIE III cases, mean value of length is 48 cm with 
standard   deviation of 3.1. 
A statistically significant association was not found between length 
and stages of HIE .(p value 0.276). 
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TABLE – 10 ASSOCIATION BETWEEN WEIGHT OF INFANTS 
AND STAGES OF HIE 
Variable Diagnosis N Mean SD p value 
Weight(kg) 
HIE I 38 3 0.52  
0.532 
 
HIE II 95 3 0.52 
HIE III 17 3 0.49 
 
The mean value of weight in HIE I and HIE II is 3 kg with 
standard deviation of 0.52. 
The mean value of weight in HIE III is 3 kg with standard 
deviation of 0.49. 
A statistically significant association was not found between 
weight and stages of HIE .(p value 0.532). 
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TABLE 11- NUMBER OF DAYS OF ADMISSION IN ALL 
STAGES OF HIE 
NICU admission 
(no.of days) 
N Mean 
Std. 
Deviation 
 
p value 
HIE 1 38 7.9 3.9 
<0.001 
HIE 2 95 11.2 4.9 
HIE 3 17 16.8 4.1 
Total 150 11 5.2 
  
The mean number of days of hospital stay in HIE I is 7.9 days with 
standard deviation of 3.9.  
The mean number of days of hospital stay in HIE II is 11.2 days 
with standard deviation of 4.9. 
The mean number of days of hospital stay in HIE III is 16.8 days 
with  standard deviation of 4.1. 
Over all mean hospital stay in all stages of HIE is 11 days with 
standard deviation of 5.2. 
A significant statistical association was found between number of 
days of  NICU stay and   severity of HIE (p value <0.001) 
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TABLE 12- ASSOCIATION BETWEEN SEVERITY OF HIE AND 
VISION AT FIRST VISIT 
Variable 
N(%) 
Diagnosis 
p value 
HIE 1 HIE 2 HIE 3 
Vision 
Normal 139 (92.6) 36 (94.7) 89 (93.7) 14 (82.4) 0.218 
 Abnormal 11   (7.3) 2   (5.3) 6   (6.3) 3 (17.6) 
 
During the first visit, visual examination was done in all HIE 
babies. 
Among the total 150 HIE cases, 139 (92.6%) cases were found to 
be normal and 11 (7.3%) cases were found to be abnormal during the first 
visit. 
Among the 38 HIE I babies, 36 (94.7%) cases were found to be 
normal and 2 (5.3%)   cases were found to be abnormal. 
Among the 95 HIE II babies, 89 (93.7%) cases were found to be 
normal and 6 (6.3%)   cases were found to be abnormal. 
Among the 17 HIE III babies, 14(82.4%) cases were found to be 
normal and 3 (17.6%)   cases were found to be abnormal. 
There was no significant statistical difference (P value 0.216) 
found between visual defect   and severity of HIE during the first visit. 
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TABLE -13 ASSOCIATION BETWEEN SEVERITY OF HIE AND 
VISION DURING FOLLOW UP 
Variable 
N(%) 
HIE I HIE II HIE III P-value
Vision 
Normal 144(96) 38 (100) 89(93.7) 17(100) 0.164 
 Abnormal 6 (4%) 0 (0) 6(6.3) 0(0) 
 
Among the 150 HIE cases, vision of 6 infants (4%) found to be 
abnormal, remaining 144 infants had normal vision during follow up 
visit. 
Among the 38 HIE I cases, vision of 2 infants found to be 
abnormal in first visit, had been found to be normal during follow up 
visit. 
Among the 95 HIE II cases, vision of 6 infants (6.3%) found to be 
abnormal in first and   follow up visit. 89 cases found to be normal. 
Among the 17 HIE III cases,vision of 3 cases found to be abnormal 
in the first visit, had been found to be normal during the follow up visit. 
There was no significant statistical difference (P value 0.164) 
between vision and severity of HIE during the follow up visit. 
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TABLE 14 CASE DISTRIBUTION OF HEARING 
ABNORMALITY AMONG 3 STAGES OF HIE 
Variables 
N(%) 
Diagnosis 
HIE 1 HIE 2 HIE 3 
Hearing
Normal 119(79.3) 35 (92.1) 75 (78.9) 9 (52.9) 
Abnormal 31 (20.6) 3   (7.9) 20 (21.1) 8 (47.1) 
 
Hearing initial assessment done in all HIE infants by using OAE 
screening. 
Among the 150 HIE cases, 119 (79.3%) cases found to be normal 
and 31 cases (20.6%) found to be abnormal by OAE screening. 
Among the 38 HIE I cases, 35(92.1%) cases found to be normal   
and 3 cases (7.9%) found to be abnormal. 
Among the 95 HIE II cases, 75 (78.9%) cases found to be normal 
and 20 (21.1%) cases found to be abnormal. 
Among the 17 HIE III cases, 9(52.9%) cases found to be normal 
and 8 (47.1%) cases   found to be abnormal. 
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TABLE 15- RESULTS OF BERA FOR HIE INFANTS WITH 
ABNORMAL HEARING SCREENING 
BERA HIE I HIE II HIE III 
Normal 3   (100) 20    (100) 7    (87.5) 
Abnormal 0      (0) 0      (0) 1    (12.5) 
 
BERA was done in HIE infants with abnormal hearing screening.  
Results were 3 cases of HIE I with abnormal hearing screening, 
found to had normal BERA (100%).  
20 cases of HIE II with abnormal hearing screening found to had 
normal BERA (100%).  
Among 8 cases of HIE III with abnormal hearing screening, 7 
cases   (87.5%) had normal BERA and 1 case (12.5%) had abnormal 
BERA. 
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TABLE 15- ASSOCIATION BETWEEN TONE ABNORMALITY 
AND   SEVERITY   OF HIE DURING FIRST VISIT 
Variable 
N (%) 
Diagnosis 
pValue 
HIE I HIE II HIE III 
Tone 
Normal 118(78.6) 37(97.4) 78 (82.1) 3(17.6) <0.001 
 Abnormal 32 (21.3) 1 (2.6) 17 (17.9) 14 (82.4) 
 
Among the 150 HIE cases, 118 cases (78.6%) had normal tone and 
32 cases (21.3%) had abnormal tone. 
Among the 38 HIE I cases, 37 cases (97.4%) had normal tone and 
1 case (2.6 %) had abnormal tone. 
Among the 95 HIE II cases, 78 cases (82.1%) had normal tone and 
1 cases(17.9 %) had abnormal tone. 
Among the 17 HIE III cases, 3 cases (17.6%) had normal tone and 
14 cases (82.4 %) had abnormal tone. 
A significant statistical difference (p value< 0.001) was found 
between tone abnormality and severity of HIE. 
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TABLE 16 - ASSOCIATION BETWEEN TONE AND SEVERITY 
OF HIE DURING FOLLOW UP USING AMIEL TISON ANGLE 
 
Tone 
N (%) 
HIE I HIE II HIE III p value 
3 month 
Normal 121 (80.6) 37 (97.4) 80 (84.2) 4   (23.5) 
0.001 
Abnormal 29   (19.3) 1   (2.6) 15 (15.8) 13 (76.5) 
6 month 
Normal 118 (78.6) 37 (97.4) 77 (81.1) 4   (23.5) 
0.002 
Abnormal 32   (21.3) 1   (2.6) 18 (18.9) 13 (76.5) 
9 month 
Normal 119 (79.3) 37 (97.4) 78 (82.1) 4   (23.5) 
<0.001 
Abnormal 31   (20.6) 1   (2.6) 17 (17.9) 13 (76.5) 
12 month 
Normal 119 (79.3) 37 (97.4) 78 (82.1) 4   (23.5) 
<0.001 
Abnormal 31   (20.6) 1   (2.6) 17 (17.9) 13 (76.5) 
 
  
60 
 
During 3rd month follow up,  
Among   the 38 HIE I cases, 37 cases (97.4%) were found to be 
normal and 1 case (2.6%) found to be abnormal. 
Among the 95 HIE II cases, 80 cases (84.2%) were found to be 
normal and 15 cases (15.8 %) found to be abnormal. 
Among the 17 HIE III cases, 4 cases(23.5%) were found to be 
normal and 13 cases (76.5%)   found to be abnormal. 
A significant statistical difference (P value 0.001) was found 
between tone abnormality and severity of HIE during 3rd month                 
follow up. 
During 6th month follow up,  
Among   the 38 HIE I cases, 37 cases (97.4%) were found to be 
normal and 1 case (2.6%) found to be abnormal. 
Among   the 95 HIE II cases, 77 cases (81.1%) were found to be 
normal and 18 cases (18.9 %) found to be abnormal. 
Among   the 17 HIE III cases, 4 cases(23.5%), were found to be 
normal and 13 cases (76.5%)   found to be abnormal. 
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A significant statistical difference (P value 0.001) was found 
between tone abnormality and severity of HIE during 6th month                 
follow up. 
During 9th month follow up, 
Same findings were seen in HIE I AND HIE III cases.  
Among the 95 HIE II cases,78   cases (82.1%) were found to be 
normal and 17 cases (17.9%) were found to be abnormal. 
A significant statistical difference (P value 0.001) was found 
between tone abnormality and severity of HIE during 9th month                  
follow up. 
During 12thmonth follow up, 
Same findings of tone abnormality were seen in HIE I, HIE II and 
HIE III cases.  
A significant statistical difference (P value 0.001) was found 
between tone abnormality and severity of HIE during 12th month             
follow up. 
 
  
62 
 
TABLE 17- ASSOCIATION BETWEEN HEAD 
CIRCUMFERENCE AND SEVERITY OF HIE DURING                    
FIRST VISIT 
Variable N Mean
Std. 
Deviation
95% Confidence 
Interval for Mean P-
Value Lower 
Bound 
Upper 
Bound 
HC 
(cm) 
HIE 1 38 34.9737 1.29504 34.5480 35.3994 
0.877 
 
HIE 2 95 34.8526 1.32519 34.5827 35.1226 
HIE 3 17 34.8118 1.63052 33.9734 35.6501 
 
During the first visit, 
Among the 38 HIE I cases, the mean head circumference was 34.9 
cm with standard deviation of 1.29. 
Among the 95 HIE II cases, the mean head circumference was 34.8 
cm with standard deviation of 1.32. 
Among the 17 HIE III cases, the mean head circumference was 
34.8 cm   with standard deviation of 1.63. 
A significant statistical difference (P value 0.877) was not found 
between head circumference and severity of HIE during first visit. 
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TABLE 18 – ASSOCIATION BETWEEN HEAD 
CIRCUMFERENCE AND SEVERITY OF HIE DURING     
FOLLOW UP 
Head 
circumference 
(cm) 
N Mean 
Std. 
Deviation 
95% Confidence 
Interval for Mean 
pValue 
Lower 
Bound 
Upper 
Bound 
3 month 
HIE 1 38 38.4286 1.63780 36.9139 39.9433 
0.894 
 
HIE 2 95 38.2455 1.73582 37.4758 39.0151 
HIE 3 17 37.9600 1.51921 36.0737 39.8463 
6 month 
HIE 1 38 41.3368 1.57350 40.8196 41.8540 
<0.001 
 
HIE 2 95 40.3084 2.14345 39.8718 40.7451 
HIE 3 17 38.5706 2.49944 37.2855 39.8557 
9 month 
HIE 1 38 42.8368 1.32674 42.4008 43.2729 
<0.001 
 
HIE 2 95 41.8274 2.22115 41.3749 42.2798 
HIE 3 17 39.9294 2.86308 38.4574 41.4015 
12 month 
HIE 1 38 44.3079 1.43854 43.8351 44.7807 
<0.001 
 
HIE 2 95 43.2684 2.34186 42.7914 43.7455 
HIE 3 17 41.2118 3.57996 39.3711 43.0524 
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During the 3rd month follow up, 
Among the 38 HIE I cases, the mean head circumference was 38.4 
cm with standard deviation of 1.63. 
Among the 95 HIE II cases, the mean head circumference was 
38.2cm with standard deviation of 1.73. 
Among the 17 HIE III cases, the mean head circumference was 
37.9cm   with standard deviation of 1.51. 
A significant statistical difference (P value 0.894) was not found 
between head circumference and severity of HIE during 3rd month follow 
up. 
During the 6th month follow up, 
Among the 38 HIE I cases, the mean head circumference was 
41.3cm with standard deviation of 1.57. 
Among the 95 HIE II cases, the mean head circumference was 
40.3cm with standard deviation of 2.14. 
Among the 17 HIE III cases, the mean head circumference was 
38.5cm with standard deviation of 2.49. 
A significant statistical difference(p value 0.001) was found 
between decrease in head circumference and severity of HIE during 6th 
month follow up. 
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During the 9th month follow up, 
    Among the 38 HIE I cases, the mean head circumference was 
42.8cm with standard deviation of 1.32. 
Among the 95 HIE II cases, the mean head circumference was 
41.8cm with standard deviation of 2.22. 
Among the 17 HIE III cases, the mean head circumference was 
39.9cm with standard deviation of 2.86. 
A significant statistical difference(p value 0.001) was   found 
between decrease in head circumference and severity of HIE during 9th 
month follow up. 
During the 12th month follow up, 
Among the 38 HIE I cases, the mean head circumference was 
44.3cm with standard deviation of 1.43. 
Among the 95 HIE II cases, the mean head circumference was 43.2 
cm with standard deviation of 2.34. 
Among the 17 HIE III cases, the mean head circumference was 
41.2cm with standard deviation of 3.57 
A significant statistical difference (P value 0.001) was found 
between decrease in head circumference and severity of HIE during 12th 
month follow up. 
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TABLE 19 – ASSOCIATION BETWEEN DDST AND SEVERITY 
OF HIE DURING FOLLOW UP 
Variable 
N(%) 
Diagnosis 
p value 
HIE 1 HIE 2 HIE 3 
DDST 
(3rd 
month) 
Normal 110 (73.3) 36 (94.7) 70 (73.7) 4 (23.5) 
<0.001 
Abnormal 40   (26.6) 2   (5.3) 25 (26.3) 13 (76.5) 
DDST 
(6th 
month) 
Normal 95   (63.3) 33 (86.8) 62 (65.3) 0    (0) 
<0.001 
Abnormal 55   (36.6) 5   (13.2) 33 (34.7) 17 (100) 
DDST 
(9th 
month) 
Normal 86   (57.3) 32 (84.2) 54 (56.8) 0    (0) 
0.004 
Abnormal 64   (42.6) 6   (15.8) 41 (43.2) 17 (100) 
 
As per DDST at 3rd month follow up, 
Among the 150 HIE cases, 110 cases(73.3%) found to be normal 
and 40 cases (26.6%) found to be abnormal. 
Among the 38 HIE I cases, 36 cases(94.7%) found to be normal 
and 2 cases (5.3%) found to be abnormal 
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Among the 95 HIE II cases, 70 cases(73.7%) found to be normal 
and 25 cases (26.3%) found to be abnormal. 
Among the 17 HIE III cases, 4 cases(23.5%) found to be normal 
and 13 cases (76.5%) found to be abnormal. 
As per DDST at 6rd month follow up, 
Among the 150 HIE cases, 95 cases(63.3%) found to be normal 
and 55 cases (36.6%) found to be abnormal. 
Among the 38 HIE I cases, 33 cases(86.8%) found to be normal 
and 5 cases (13.2%) found to be abnormal.  
            Among the 95 HIE II cases, 62 cases(65.3%) found to be normal 
and 33 cases (34.7%) found to be abnormal. 
            Among the 17 HIE III cases, 17 cases (100%) found to be 
abnormal. 
As per DDST at 9th   month follow up, 
Among the 150 HIE cases, 86 cases(57.3%) found to be normal 
and 64 cases (42.6%) found to be abnormal. 
Among the 38 HIE I cases, 32 cases(84.2%) found to be normal 
and 6 cases (15.8%) found to be abnormal 
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Among the 95 HIE II cases, 54 cases(56.8%) found to be normal 
and 41 cases (43.2 %) found to be abnormal. 
Among the 17 HIE III cases, 17cases (100%) found to be 
abnormal. 
A significant statistical association (P value 0.004) was found 
between denver developmental screening test and severity of HIE during 
3rd,6th ,9th month follow up. 
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TABLE 20 – ASSOCIATION BETWEEN SEVERITY OF HIE AND 
DEVELOPMENTAL DELAY IN DASII AT THE END OF 
FOLLOW UP (12 MONTH)  
Variable 
Diagnosis 
pValue 
HIE 1 HIE 2 HIE 3 
DASII 
Normal 81 (54) 32   (84.2) 48 (50.5) 1   (5.9) <0.001 
 Abnormal 69 (46) 6   (15.8) 47 (49.5) 16 (94.1) 
 
At the end of follow up (12th month) 
Among the 38 HIE I cases, 32 cases(84.2%) found to be normal  
and 2 cases(15.8%) found to be abnormal. 
Among the 95 HIE II cases, 48 cases(50.5%) found to be normal 
and 47 cases(49.5%) found to be abnormal. 
Among the 17 HIE III cases, 1 case (5.9 %) found to be normal 
and 16 cases(94.1 %) found to be abnormal. 
A significant statistical association (P value 0.001) was found 
between severity of HIE and developmental delay as per DASII at the 
end of 1 year follow up. 
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FIGURE 9- ASSOCIATION BETWEEN SEVERITY OF HIE AND 
DEVELOPMENTAL DELAY IN DASII AT THE END OF 
FOLLOW UP (12 MONTH) 
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TABLE 21 - COMPARISION OF DEVELOPMENT OF HIE 
INFANTS AS PER DDST DURING FOLLOW UP AND DASII AT 
THE END OF FOLLOW UP.  
Variable 
DASII 
Normal Abnormal 
DDST (3 month) 
Normal 78 32 
Abnormal 3 37 
DDST (6 month) 
Normal 80 15 
Abnormal 1 54 
DDST(9 month) 
Normal 81 5 
Abnormal 0 64 
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TABLE 22- SENSITIVITY, SPECIFICITY, POSITIVE 
PREDICTIVE VALUE, NEGATIVE PREDICTIVE VALUE AND 
DIAGNOSTIC ACCURACY OF DDST 
Parameter(DDST) Sensitivity Specificity
PP 
Value 
NP 
Value 
Diagnostic 
Accuracy 
3rd month 96.3% 53.62% 70.91% 92.5% 76.67% 
6th month 98.77% 78.26% 84.21% 98.18% 89.33% 
9th month 100% 92.75% 94.19% 100% 96.67% 
 
During 3rd month follow up, the sensitivity and specificity to 
identify developmental delay by DDST were 96.3% and 53.62%. Positive 
predictive value was 70.91% and negative predictive value was 92.5%.  
Overall diagnostic accuracy was 76.67%.  
During 6th month follow up, the sensitivity and specificity to 
identify developmental delay by DDST were 98.77% and 78.26%. 
Positive predictive value was 84.21 % and negative predictive value was 
98.18 %.  
Overall diagnostic accuracy was 89.33%. 
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During 9th month follow up, the sensitivity and specificity to 
identify developmental delay by DDST were 100% and 92.75%. Positive 
predictive value was 94.19 % and negative predictive value was 100 %. 
Overall diagnostic accuracy was 96.67%. 
 
TABLE 23- ASSOCIATION BETWEEN DEVELOPMENTAL 
DELAY AMONG THE HIE INFANTS AND NEONATAL REFLEX 
Variable 
N (%) 
DASII 
p Value 
Normal Abnormal 
NNR 
normal 138   (92) 78   (96.2) 60   (86.9) 0.321 
 abnormal 12   (8%) 3    (3.7) 9      (13) 
 
Among the 150 HIE cases, 138 cases (92 %) had normal neonatal 
reflex and 12 cases (8%) had abnormal neonatal reflex. 
Among the 81 cases with normal developmental outcome by 
DASII, 78 cases(96.2%) had normal neonatal reflex and 3 cases (3.7%) 
had abnormal  neonatal reflex. 
Among the 69 cases with delayed developmental outcome by 
DASII, 60 cases (86.9%) had normal neonatal reflex and 9 cases(13%) 
had abnormal neonatal reflex. 
A significant statistical difference (P value 0.321)   was not found 
between neonatal reflex and developmental delay among HIE infants. 
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TABLE 24 - ASSOCIATION BETWEEN DEEP TENDON REFLEX 
AND DEVELOPMETAL DELAY AMONG HIE INFANTS 
Variable 
N(%) 
DASII 
p Value 
Normal Abnormal 
DTR 
Normal 85 (56.6) 77 (95.1) 8 (11.6) <0.001 
 Abnormal 65 (43.3) 4 (4.9) 61(88.4) 
 
Among 81 cases wih normal developmental outcome, 77 cases 
(95.1%) had normal DTR and 4 cases (4.9%) had   exaggerated   DTR. 
Among 69 cases wih delayed developmental outcome, 8 cases 
(11.6%) had normal DTR and 61 cases (88.4%) had exaggerated DTR. 
A significant statistical association (P value 0.001) was found 
between abnormal deep tendon reflex and developmental delay among 
HIE nfants. 
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TABLE 25- ASSOCIATION BETWEEN DEVELOPMENTAL 
DELAY AMONG HIE INFANTS AND THEIR NEUROIMAGING 
Variable 
N(%) 
DASII 
p Value 
Normal Abnormal 
Neuroimaging 
Normal 59 (39.3) 46   (56.8) 13 (18.8) 
<0.001 
 
Mild Changes 62 (41.3) 34   (42) 28 (40.6) 
Severe Changes 29 (19.3) 1   (1.2) 28 (40.6) 
 
Among the 150 HIE cases, 59 cases (39.3%) had normal 
neuroimaging, 62 cases (41.3%) had mild HIE changes, 29 cases (19.3%) 
had severe HIE changes in neuroimaging. 
Among 81 HIE infants with normal developmental outcome, 46 
cases (56.8%) had normal cranial imaging, 34 cases(42%) had mild 
changes in cranial imaging and 1 case (1.2%) had severe changes in 
cranial imaging. 
Among 69 HIE infants with delayed developmental outcome, 13 
cases (18.8%) had normal cranial imaging, 28 cases(40.6%) had mild 
changes  in cranial imaging and 28 cases (40.6 %) had severe changes in 
cranial imaging. 
A significant statistical association (P value 0.001) was found 
between   developmental delay among HIE infants and   cranial imaging. 
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DISCUSSION 
Hypoxic ischemic encephalopathy (HIE) is known to be associated 
with significant morbidity and mortality in the full term infant. 
This study was conducted to identify neurodevelopmental outcome 
of HIE infants and their outcome in relationship with the severity of HIE. 
During the study period from march 2016 to October 2017, 150 
HIE infants were followed. Among them more than half of the infants 
had HIE II and one third of the infants had HIE I and remaining were 
HIE III. The number of male infants were proportionately high in HIE I 
and HIE II and female infants are more in HIE III. 
Infants with HIE, those delivered by primi mothers are more than   
multigravida mothers. HIE was more common in outborn babies than 
inborn babies. 
Among the complications, shock and multiorgan dysfunction were 
more common in HIE III infants. Among the multiorgan dysfunction, we 
observed that acute kidney injury is most common [9].  
We also observed that there was no significant statistical 
correlation with weight and length of the HIE infants and the severity of  
HIE. There was significant statistical association between severity of HIE 
and increase in number of   days of NICU admission.  
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We found out a significant statistical association between tone 
abnormality and severity of HIE at first visit   and 3rd , 6th, 9th , 12th month 
follow up visit.    
There was a significant statistical correlation between the decrease 
in head circumference and severity of HIE during 6th, 9th, 12th month 
follow up visit. This correlates with Charlene et al [4] who stated that a 
decrease of head circumference growth in the early months, as  
determined by serial measurements, is associated   with adverse outcome. 
By DASII, some of   HIE I infants, half of the HIE II infants, 
nearly all HIE III infants had developmental delay (DQ < 70). 15.8 % of 
HIE I infants, 49.5 % of HIE II and 94.1 % of HIE III had abnormal 
neurodevelopmental outcome[9] . In our study, percentage of abnormal 
neurodevelopmental outcome in HIE I infants were slightly high. 
At 3rd month follow up, nearly all HIE I infants had normal DDST, 
one fourth of   HIE II infants, two third of HIE III infants had abnormal 
DDST. It has sensitivity of 96.3 % and specificity of 53.6 % with overall 
diagnostic accuracy of 76.67% at 3rd month follow up. 
At 6th month follow up, one seventh of   HIE I infants, one third of  
HIE II infants, and all infants of HIE III had abnormal DDST. It has 
78 
 
sensitivity of 98.7 % and specificity of 78.2 %   with overall diagnostic 
accuracy of 89.33% at 6th month follow up. 
At 9th month follow up, one seventh of HIE I infants, one half of 
HIE II infants, and all   infants of HIE III had abnormal DDST. It has  
sensitivity of 100% and specificity of 92 % with overall diagnostic 
accuracy of 96.67 % at 9th month follow up. 
We observed significant statistical association between 
neuroimaging abnormality and severity of HIE. Thus, neuroimaging may 
helps to predict neurodevelopmental outcome in term infants with HIE. 
This finding was similar to the study done by Rebia et al[2] . 
At first visit, 2 out of 38 HIE I infants, 6 out of 95 HIE II infants, 2 
out of 17 HIE III infants had abnormal fundus findings. Some of them 
had bilateral temporal pallor, some had retinal hemorrage, few had 
retinopathy of prematurity also. 
During follow up visit, there was decrease in abnormal fundus 
findings only 6 infants had abnormal fundus findings, remaining were 
found to be normal. Also we found out that some of infants who have 
normal fundus examination in previous visit developed convergent squint 
during follow up visit. 
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Also we observed no statistical significance between visual  
abnormality and severity of HIE. 
By OAE screening test, 3 out of 38 HIE I infants, 20 out of 95 HIE 
II infants, 8 out of 17 HIE III infants had abnormal screening test. Those  
who have abnormal screening   were undergone BERA and found out to 
be one abnormal. 
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RECOMMENDATIONS 
From our study, we suggest   follow up of all stages of HIE infants 
had significant role to detect developmental delay   earlier. Hence they 
may be enrolled for early intervention to prevent severe sequelae. 
Denver Developmental Screening Test (DDST) had been used in 
our study with reasonable sensitivity, specificity and diagnostic accuracy 
when compared with DASII (Developmental Assessment Scale For 
Indian Infants). Hence DDST can be used for follow up developmental 
assessment in office practice since it is less time consuming with good 
diagnostic accuracy. 
Visual and hearing assessment is mandatory along with 
developmental assessment during follow up of HIE infants. 
Neuroimaging   may help to predict the neurodevelopmental outcome of 
term infants with HIE. 
Also head circumference and tone abnormality helps to predict 
developmental outcome on follow up. 
 
 
 
 
 
 
 
 
 
LIMITATIONS 
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LIMITATIONS 
Number of infants in HIE I and III were less when compared to 
HIE II infants in our cohort. 
MRI brain could not be done in all cases. 
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PROFORMA 
 
Name   :                                      DOB   : 
Age/ sex :                                     B.wt   : 
Address   :                                   Inborn/Outborn  
Contact no:  
AN H/O   :   G P L A  
H/O GDM /PIH /Maternal fever /APH  
AN scan abnormality - 
Birth H/O :   gestational age -  
NVD/AVD/Emergency LSCS/elective LSCS 
B.wt - SGA/AGA/LGA 
Resuscitation - no need /need /apgar 
PN H/O   :   N ICU admission (no of days) : 
NNC : +/_ duration of AEDs : 
Ventilation :   not required / uncomplicated course/> 7 days 
Shock : no / yes / refractory 
Hypoglycaemia : transient /<25 mg for > 3 days/symptomatic 
multiorgan injury   : +/_ 
sepsis : suspected / sepsis / meningitis 
NNJ : phototherapy/exchange transfusion/ kernicterus 
 
DBF on -    th day                  ABX   -    days 
DIAGNOSIS - 
At discharge   : neurological examination NORMAL / severe prolonged  
encephalopathy / abnormal with suspect developmental delay 
Home environment: good / suboptimal 
Examination 
Length    : 
Weight    : 
HC       : 
Tone       :   hypo / hyper      symmetric/asymmetric  
    NNR       :   +/- 
    DTR       :   +/- 
  Vision     : 
Hearing    : 
INVESTIGATIONS 
CT brain/ NSG / MRI brain : 
    Vision   : 
  Hearing : 
Others : 
 
  
                                                                                        FOLLOW  UP                                                                                                             
Overall assessmentof neuromotor and developmental status  ( 3,6,9,12,15 months ) 
date CA tone 
Develop
mental 
age 
HC Seizures+/_ 
Involuntary 
movements
+/- 
vision hearing others 
Normal/ 
Suspect/ 
abnormal 
           
           
           
           
           
 
Muscle tone assessment ( amiel tison ) 
Age( mon) date Adductor angle  
Popliteal 
angle  
Dorsiflexion 
angle  Scarf sign 
  0-3  40-80  80-100  60-70  Elbow not cross midline 
 4-6  70-120  90-120         ”        Crosses midline 
 7-9  110-140  110-160          ”  Goes beyond axillary line 
10-12  140-160  150-170          ”   
 
 
 
 
 
 
MASTER CHART 
  
       name      sex   GPLA antenatal  risk     O/I
mode of 
delivery
resuscitati
on
NICU 
admission NNC
Ventilati
on   shock
hypoglycem
ia
multi 
organ 
injury sepsis diagnosis length wt
baby.nithin m 1 1 O 1 2 13    +  -  -  -  -  - HIE 2 46 2.6
b/o nithya m 1    - o 1 2 14     +  + -  - AKI  - HIE 3 48 3.2
b/o kanimzhi m 2 2 I 3 - 7     +   -  -  -  -  - HIE 2 47 4
b/o geetha m 1    - o 1 3 20 -   +  +  - +  + HIE 3 45 2.7
b/o riswanabarwin m 1 1 I 1 2 7    -   -  -  -  -  + HIE 1 46 2.9
 b/o veerammal m 2    - o 1 2 10  +   -  -  -  -  - HIE 2 45 3
b/o laxmi m 1 3 I 1 1 5   -  -  - - - - HIE 1 45.2 2.8
b/o chingapandi m 1  - O 1 2 15 +  - - - - - HIE2 48 2.8
b/o vasuki m 2 1 I 1 2 7 +  - - - - - HIE2 52 3.5
b/o rajalaxmi m 1 3 I 1 2 10 -  - - - - + HIE1 52 4
b/o kaviyasri f 2  - I 1 1 10 +  - - - - - HIE2 48 2.5
b/o sathya f 2  - I 1 3 15 +  + + - - + HIE2 46.8 2.5
b/o solaiammal f 1  - O 1 1 15 +  - - - - + HIE2 47 3
baby venkateshwari f 2 1 O 1 2 14  +  -  -  -  -  + HIE2 48.5 3.5
b/o kokila f 2  - O 2 2 20 +  + + - + + HIE3 44.5 3.2
b/o verammal m 1  - I 1 1 14 +  - - - - + HIE2 52 2.7
b/o janaki m 1  - O 1 2 18 +  - - - - - HIE2 52 3.5
b/o umesh m 1 1 I 3 2 6 -  - - - - - HIE1 51 2.8
b/o devi f 2  - I 1 1 1 +  - - - - - HIE2 50 2.6
b/o kavitha m 2  - O 2 2 17  +  +  +  - AKI+  + HIE3 49 2.5
b/o nishanti m 2  - O 1 2 7 +  - - - - - HIE2 48.5 2.6
b/o rajeshwari f 1  - O 1 2 20 -  + + - - + HIE3 47.8 2.4
b/o  sumathy f 1  - O 1 1 7 +  - - - - - HIE2 46.5 2.3
baby 
veeramanikandan m 1 1 O 1 2 12  +  -  -  -  -  - HIE2 48 2.5
b/o pandeshwari m 1  - O 1 2 13 +  - - - - - HIE2 49 2.8
siddharth m 1 1 O 1 2 14  +  -  -  -  -   +
HIE2/sepasi
s 48.2 2.1
krithick m 1 1 O 1 2 9 +  CPAP2d - - - + hie2/msa 46 3.7
sabirashree f 1 2 I 3 3 7 - CPAP 1d - - - - HIE1 50 3.2
sanjanashree f 1  - I 1 1 8 +  - - - - - HIE2 51 3.2
b/o karuppayya m 2 1 I 4 2 25 + CPAP 1d - - - + HIE2 52 2.8
b/o asaikili m 1  - I 1 2 6 +  - - - - - HIE2 52.1 3.2
b/o nandhini m 1 1 I 2 3 13 -  - - - - - HIE1 47 3
madhara m 1  - O 1 2 15 + CPAP 1d - - - + HIE2 48.2 3
b/o vanitha m 2 2 O 1 2 5 -  - - - - - HIE1 49.6 2.5
b/o vijayalaxmi m 2  - I 1 2 4 +  - - - - - HIE2 45.2 3.5
nadashree f 1  - I 3 2 17 +  - - - + HIE2 46.5 2.5
b/o meenakshi m 1  - I 1 2 9 + CPAP 1d - - - + HIE2 47 2.5
veeramanikandan m 2 1 O 1 2 8 +  - - - - - HIE2 48 3.5
b/o bhuvaneshwari m 1 2 I 3 - 3 -  - - - - - HIE1 47 1.75
sivarithishri f 1 1 I 1 2 9 +  - - - - + HIE2 48 4.3
dhivnesh m 1  - I 3 2 7 + CPAP 2D - - - + HIE2 47 2.75
jeeva m 1 1 I 3 2 7 -  - - - - - HIE1 50 3.5
b/o sundaradevi m 1 2 I 1 2 7 -  - - - - - HIE1 50 3.5
aniruth m 1 3 I 3 2 15 -  - - - - + HIE1 50.2 3.2
b/o indira f 1  - I 1 2 15 +  - - - - - HIE2 51 3
b/o gee tha m 1 1 O 1 2 13 +  - - - - - HIE2 46 2.6
b/o vanitha f 1  - O 1 2 14 +  + + - + - HIE3 48 3.2
b/o vijaya m 2  - I 3 - 7 +  - - - - - HIE2 47 4
b/o boomani m 1  - O 1 3 20 +  + + - - + HIE3 45 2.7
b/o shanmugasundari m 1 1 I 1 2 7  -  -  -  -  -  + HIE1 46 2.9
b/o anusha m 2  - O 1 2 10 +  - - - - - HIE2 45 3
b/o  veni f 1 2 I 1 1 5 -  - - - - - HIE1 47 2.8
b/o saraswathi m 1  - O 1 2 15 +  - - -  - - HIE2 48 2.8
b/o devi f 2  - I 1 2 7 +  - - - - - HIE2 52 3.5
b/o poornima f 1 1 I 1 2 10 -  - - - - + HIE1 52 4
b/o prakashi f 2  - I 1 1 10 +  + - - - - HIE2 50 3.5
b/o selvi f 2  - I 1 3 15 +  + + - AkI + HIE3 51 2.5
b/o seetha f 2  - O 1 1 15 +  - - - - + HIE2 51.2 2.8
b/o madhu f 1  - O 1 2 14 +  - - - - + HIE2 50.3 2.9
b/o amaravathi f 2  - O 1 2 20 +  + + - + + HIE3 52 2.9
b/o kani f 2 1 I 1 1 14 +  - - -     - + HIE2 52 2.7
b/o murkeshwari m 1  - O 1 2 18 +  - - - - - HIE2 52 3.5
b/o parvathasri m 1 1 I 3 2 6 +  - - - - - HIE2 51 2.8
b/o majula f 2  - I 1 1 7 -  - - - - - HIE1 50 3.5
b/o sorna m 2  - O 2 2 17 +  + - - - - HIE2 50 3.4
b/o devi m 2 1 O 1 2 7 +  - - - - + HIE2 50 3.9
b/o nayaki f 1  - O 1 2 20 +  + + - - - HIE3 49 2.8
b/o baby f 1  - O 1 1 7 +  + - - - + HIE2 55 4.1
b/o sutha m 1  - O 1 2 12 +  - - - - - HIE2 49.5 2.9
b/o parvathi m 1  - O 1 2 13 +  - - - - - HIE2 49 2.7
b/o afrin m 1  - O 1 2 14 +  - - - - - HIE2 48 2.1
b/o aarthi m 1 1 O 1 2 9 +  + - - - + HIE2 48.2 3.7
b/o anandhi f 1  - I 3 3 7 +  + - - - + HIE2 48.7 3.2
b/o sachu f 1 1 I 1 1 8 -  - - - - - HIE1 47 3.2
b/o uma m 2 1 I 4 2 25 +  + - - - - HIE2 45 2.8
b/o mangai m 1 1 I 1 2 6 +  - - - - + HIE2 46 3.2
b/o bavani m 1  - I 2 3 13 +  - - - - - HIE2 46.7 3
b/o gowri m 1 1 O 1 2 15 -  - - - - - HIE1 45.5 3
b/o vasanthi m 2  - O 1 2 5 +  - - - - + HIE2 48 2.5
b/o kavitha m 2  - I 1 2 4 -  - - - - - HIE1 48 3.5
b/o subha f 1  - I 3 2 17 +  - - - - - HIE2 49 2.5
b/o chithra m 1  - I 1 2 9 +  + - - - + HIE2 49.2 2.5
b/o selvi m 2  - O 1 2 8 +  - - - + + HIE2 50 3.5
b/o soniya m 1  - I 3 - 3 +  - - - - - HIE2 50.6 1.75
b/o sneha f 1  - I 1 2 9 -  - - - - - HIE1 50.8 4.3
b/o chandra m 1  - I 3 2 7 -  - - - - + HIE1 50 2.75
b/o divya m 1 1 I 3 2 7 +  - - - - + HIE2 49 2.75
b/o kumari m 1  - I 1 2 7 +  - - - - - HIE2 48 3.5
b/o sangari m 1  - I 3 2 15 -  - - - - - HIE1 48 2.5
b/o muhila m 1 1 O 1 2 13 -  - - - - + HIE1 46 3
b/o viji f 1  - O 1 2 14 -  - - - - - HIE1 48 3.2
b/o lalitha m 2  - I 3 - 7 +  -  - - - - HIE2 47 4
b/o malathi m 1  - O 1 3 20 +  + + - + - HIE3 45 2.7
b/o padhma m 1 1 I 1 2 7 +  - - - - + HIE2 46 2.9
b/o bharathi m 2  - O 1 2 10 +  - - - + + HIE3 48 3
b/o sri devi f 1  - I 1 1 5 -  - - - - - HIE1 49 2.8
b/o mumtaj m 1  - O 1 2 15 +  - - - - - HIE2 49 2.8
b/o amutha f 2  - I 1 2 7 -  - - - - - HIE1 52 3.5
b/o rani f 1 1 I 1 2 10 +  - - - - - HIE2 52 4
b/o viji m 2  - o 1 2 4 -  - - - - - HIE1 51 2.5
b/o ananthi   M 1  - I 1 1 14 +  - - - - + HIE2 52 2.7
b/o  selvarani M 1  - O 1 2 18 +  - - - - - HIE2 52 3.5
b/o maheshwari M 1 1 I 3 2 6 -  - - - - - HIE1 52 2.8
b/o Thivya F 2  - I 1 1 7 +  - - - - - HIE2 50 2.5
b/o pushpam M 1  - O 2 2 17 +  + - - AKI+ + HIE2 52 2.8
b/o nishanti M 2  - O 1 2 7 +  - - - - - HIE2 51 2.9
b/o nirmala F 1  - O 1 2 20 -  + + - - + HIE3 52 3
b/o malathy F 1  - O 1 1 7 +  - - - - - HIE2 55 4.1
b/o gowsi M 1 1 O 1 2 12 +  - - - - - HIE2 46 2.6
b/o bagavathy m 1 1 O 1 2 13 +  - - - - - HIE2 48 3.2
b/o indhu mathi f 1  - O 1 2 14 +  + + - - - HIE3 47 4
b/o iswariya m 2  - I 3 - 7 +  - - - - - HIE2 45 2.7
b/o hema m 1 3 O 1 3 20 -  + + - + + HIE3 46 2.9
b/o jisha m 1 1 I 1 2 1 -  - - - - + HIE1 42.5 3
b/o preethi m 2  - O 1 2 10 +  - - - - - HIE2 47 2.8
b/o nachiyar f 1  - I 1 1 5 -  - - - - - HIE1 48 2.8
b/o varsha m 1  - O 1 2 15 +  - - - - - HIE2 48 3.5
b/o afrin f 2  - I 1 2 7 +  - - - - - HIE2 52 4
b/o banu f 1 1 I 1 2 10 -  - - - - CRP+ HIE1 52 3.5
b/o selva kumari f 2  - I 1 1 10 +  - - - - - HIE2 52 2.5
b/o brintha f 2 2 I 1 3 15 +  + + - + + HIE3 50 2.5
b/o harini f 1  - O 1 1 15 +  - - - - + HIE2 51 2.9
b/o saroja f 2  - O 1 2 14 +  - - - - + HIE2 51 2.8
b/o anubraba f 2 1 O 2 2 20 +  + + - + + HIE3 44.5 2.7
b/o nanthini m 1 2 I 1 1 14 +  - - - - + HIE2 52 2.7
b/o esakkiammal m 1 2 O 1 2 18 +  - - - - - HIE2 52 3.5
b/o pavithra m 1 1 I 3 2 6 +  - - - - - HIE2 52 2.8
b/o karthika f 2  - I 1 1 1 -  - - - - - HIE1 48 2.6
b/o lavaniya m 2  - O 2 2 17 +  + - - AKI+ + HIE2 49 2.5
b/o bavani m 1  - O 1 2 13 +  - - - - - HIE2 48 2.8
b/o jayanthi m 1 1 O 1 2 14 +  - - - - + HIE2 48 2.1
b/o kalyani m 1 1 O 1 2 9  + CPAP 2d  -  -  -  + HIE2 49 3.7
b/o pappu f 1 1 I 3 3 7 - CPAP1d - - - - HIE1 47 3.2
b/o avudaiammal f 1 2 I 1 1 8 +  - - - - - HIE2 47 3
b/o seyad ali fathima m 2 1 I 4 2 25  + CPAP 1d  -  -  -  + HIE2 47 2.8
b/o mary grace m 1  - I 1 2 6 +  - - - - - HIE2 47.8 3.2
b/o joy rani m 1  - I 2 3 13 -  - - - - - HIE1 47.9 3
b/o nagash wari m 1  - O 1 2 15 + CPAP1d - - - + HIE2 48 3
b/o bakiyam m 2  - O 1 2 5 -  - - - - - HIE1 45 2.5
b/o sumithra m 2  - I 1 2 4 +  - - - - - HIE2 48 3.5
b/o renuka f 1  - I 3 2 17 +  - - - - + HIE2 49 2.5
b/o rukmani m 1 3 I 1 2 9 + CPAP1d - - - + HIE2 50 2.5
b/o banumathi m 2 1 O 1 2 8 +  - - - - - HIE2 51 3.5
b/o soranam m 1 3 I 3 - 3  -  - - - - - HIE2 52 1.75
b/o letricia f 1 1 I 1 2 9 -  - - - - + HIE1 51 4.3
b/o piramachi m 1  - I 3 2 7  +  CPAP1d  -  -  -  + HIE2 52 2.75
b/o leema m 1 1 I 3 2 7 +  - - - - - HIE2 50 2.3
b/o logamal m 1  - I 1 2 7 -  - - - - - HIE1 52 3.5
b/o priya sundari m 1  - I 3 2 15 -  - - - - + HIE1 50 2.5
b/o deepa f 2    - o 3 1 5 -  - - - - - HIE1 46 3
     hc tone NNR DTR
neuroimagi
ng  vision hearing     hc1 tone1 ddst1     hc2 tone2 ddst2     hc3 tone3 Vision 2 hearing2 ddst3 hc4 tone4 dasii
34.6    N   +  + 2      N 1 37    N    N 39    N     N 40     N N    N    N 41   N   N
34 1   +   ++ 3 1 2 37 1    N 40 2 S 42 2  N    N DD 44 2 3
37     N   +  + 2   N 1 39    N    N 40    N     N 41     N   N    N    N 41.5    N N
36.5 1    + ++ 3    N 1 38 1 S 39 2 DD 41 2  N   N    DD 43 2 3
36    N    +   + 1    N 1 38    N     N 40    N     N 41    N  N    N    N 42    N     N
36 1   -  - 3 1 1 36 1 S 37 2 DD 38 2  N    N DD 38.5    N 3
36.2   N  - + 1   N 1 35   N  N 37    N    N 40     N  N   N   N 42  N     N
35 N + + 2 2 1 39 N N 42 N N 42 N N N S 43 N 1
36 N + + 1 N 1 39 N N 41.5 N N 43 N N N N 45 N N
36 N + + 1 N 1 38 N N 40 N N 43 N N N N 45 N N
34.7 N + + 2 2 1 37 N N 39.5 N N 42 N N N N 44 N N
33 1 + - 3 N 2 33.2 2 DD 33.5 2 DD + 34 2 N N DD 34 2 5
34 N + + 2 N 2 37 N N 39.5 N N 41.3 N N N N 43 N N
33 N  +  - 2 N 1 35 N N 37.5 2 DD + 38 2 squint + N DD 40 2 3
36 2 + ++ 3 1 2 36 2 S 35.8 2 DD + 36.5 2 N N DD 37 2 4
36 N + + 2 N 1 38 N N 41 N N 43 N N N N 45 N 1
35.5 1 + - 3 1 1 36 1 DD 36 1 DD + 36.8 1 N N DD 38 1 4
33 N + + 1 N 1 37 N N 41 N N 43 N N N N 45 N N
33 N + + 2 N 1 35 N N 39 N N 42 N N N N 44 N N
35.8 1  -  - 3 1 2 37 1 S 39 2 DD 41 2 N
ABNORM
AL DD 45 2 3
34 1 + + 2 N 1 38.5 N N 41 N N 42.5 N N N N 44 N N
35 2 + ++ 3 N 1 36 2 S 36.5 2 DD 37 2 N N DD 37 2 3
34.5 N + - 2 N 1 37 N N 39 N N 42 N N N S 44 N 1
33 N  +  + 2 N 1 36 N N 39 N N 42 N N N N 45 N N
33 N + - 2 N 1 37 N DD 40 N DD 43 N N N DD 45 N 4
35 1  -  - 3 2 1 37 2 DD 37.5 2 DD 38 2 N N DD 39 2 5
34 N + + 2 N 1 35 N N 37 N N 40 N N N N 43 N N
37 N + + 1 N 1 41.5 N N 43 N N 44 N N N N 45 N N
35 1 - - 3 N 1 37 1 DD 38.5 1 DD 39 1 N N DD 39.2 1 4
37 N + + 2 N 1 39 N N 42 N N 43 N N N N 44.2 N N
33 N + + 2 N 1 36.5 N N 39.5 N N 41 N N N N 43 N N
35 N + - 1 N 1 37 N N 39 N DD 40.5 N N N DD 42 N 3
34 N + + 2 N 1 39 N N 41.5 N N 43 N N N N 45 N N
34 N + + 1 N 1 36 N N 38 N N 41.5 N N N N 43 N N
34 N + + 2 N 1 37 N N 39.5 N S 40.5 N N N S 43 N 2
32 N + + 3 N 1 33 N N 34 N N 36 N squint + N N 38 N N
35 N + + 2 N 1 39.7 N N 42 N N 43.5 N N N N 45 N N
38 N + - 2 N 2 39.5 N N 42 N N 46 N N N S 47 N 2
35 N + - 1 N 1 38 N N 41 N S 41.5 N N N DD 42.5 N 3
35 N + + 2 N 1 38 N N 42 N N 44 N N N N 45 N N
35.2 N + + 2 N 1 37 N N 42.5 N N 44 N N N N 45.2 N N
33 N + + 1 N 1 37 N N 40 N N 42.5 N N N N 43.5 N N
35.5 N + + 1 N 1 39.5 N N 41.5 N N 43 N N N N 45 N N
34 N + + 1 N 1 39.8 N N 41 N N 42 N N N N 43.6 N N
33 N + + 1 N 1 37 N N 40 N N 42.7 N N N N 44 N N
34.6 N + + 2 N 1 37 N N 39.9 N N 41.5 N N N N 43 N N
32.5 N + ++ 3 1 1 35 N N 38 N S 40 N N N DD 42 N 3
37 N + + 2 N 2 38 N N 40 N N 41.5 N N N N 43 N N
36.5 1 + - 3 N 1 38 1 S 39 2 DD 41 2 N N DD 41.2 2 3
36 N  +  + 1 N 2 40 N N 42 N N 43 N N N N 44.2 N N
36 1 + - 3 1 1 39.8 1 S 41 2 DD 41.7 2 N N DD 43 2 3
36.2 N + + 1 N 1 40.5 N N 42.7 N N 44 N N N N 45 N N
35 N + - 2 2 2 39 N N 42 N N 43.5 N N N S 45 N 1
34 N + + 2 N 1 39.7 N N 42 N N 43.5 N N N N 44.8 N N
36 N + + 1 N 1 39 N N 41.2 N N 43 N N N N 44.7 N N
34.7 N + + 2 2 1 37.8 N N 39.5 N N 41.5 N N N N 43 N N
33 1 + - 3 N 2 33.2 2 DD+ 33.5 2 DD+ 34 2 N N DD 34 2 5
33 N  + + 1 N 2 37 N N 39.5 N N 41 N N N N 42.8 N N
33 N + - 2 N 1 38 N N 37.5 2 DD+ 39 2 squint + N DD 40 2 3
36 2 + - 3 2 2 38 2 S 40.5 2 DD+ 42 2 N N DD 43.7 2 4
36 N + + 2 N 1 36.2 N N 39 N S 41 N N N S 43 N 1
35.5 1 +  - 3 1 1 36 1 DD 37 1 DD+ 37.8 1 N N DD 38 1 4
34 N + + 1 N 1 40 N N 43 N N 44 N N N N 45 N N
35 N + + 2 N 1 40 N N 42.5 N N 44 N N N N 45.8 N N
33 N + ++ 1 1 2 39 N S 41 N DD 42.7 N N N DD 43 N 2
33.5 1 - - 2 N 1 38 N N 41 N N 42.8 N N N N 44 N N
34.5 2 + ++ 3 N 1 39.5 2 S 40.2 2 DD 42 2 N N DD 42.7 2 3
33 N + + 2 N 1 37.5 N N 39.8 N N 41.8 N N N N 43 N N
34 N + - 2 N 1 39.8 N N 41.5 N DD 43 N N N DD 45 N 3
34.2 N + - 1 N 1 37 N N 41 N N 42.8 N N N N 44 N 1
35 1 - - 3 2 1 40 2 DD 41 2 DD 41.2 2 N N DD 43.6 2 4
34 N + ++ 2 N 1 38 N DD 41 N DD 42 N N N DD 42.3 N 4
33.5 N  + - 1 N 1 38 N N 40 N N 41.8 N N N S 44 N 1
35 1 - ++ 2 N 1 36.5 1 N 37 1 S 38 1 N N DD 38.2 1 3
37 N + ++ 2 2 39 N DD 40.7 N DD 42 N N N DD 43.8 N 4
36 N + + 2 N 1 39.5 N N 42 N N 43.5 N N N S 45 N 1
35 N + + 2 1 1 38 N N 41 N N 42.5 N N N N 44 N N
35 N + + 1 N 1 38 N N 40.8 N N 42 N N N N 44.2 N N
33.6 N + - 2 N 38 N DD 41 N DD 43 N N N DD 45 N 3
34 N + + 1 N 1 39 N N 41.3 N N 43 N N N N 44.7 N N
32 N + + 2 N 1 33.5 N N 34 N N 36 N squint + N N 38 N N
35 N +  + 2 N 1 39 N N 42.8 N S 43 N N N S 44.8 N 2
35 N + + 1 N 2 38 N N 42 N N 43.6 N N N N 45 N N
35 N + - 2 N 1 39 N N 41.6 N S 43 N N N DD 45 N 2
33 N + - 1 N 1 38 N N 42 N N 44 N N N S 45.2 N 2
32 N + + 2 N 1 37 N N 42.5 N N 43.5 N N N N 44.8 N N
34.2 N + + 1 N 1 39 N N 42 N N 42.8 N N N N 43.5 N N
35.5 N + + 1 N 2 41 N N 42.8 N N 43 N N N N 44.2 N N
35 N + + 1 N 1 40 N N 41 N N 42 N N N N 44 N N
34.6 N + + 2 N 1 40 N N 43 N N 43.8 N N N N 45 N N
32.5 N + + 2 1 1 41 N N 42.5 N N 44 N N N N 45.2 N N
37 N + - 2 N 1 38 N S 41 N S 43 N N N S 44.2 N 1
36.5 1 + - 3 N 1 40 1 N 39 1 DD 41 N N N DD 43 N 4
36 N + + 2 N 1 39 1 S 41.8 N N 43 N N N N 45 N N
36 1 - - 3 1 2 39.8 N DD 41 2 DD 41.5 2 N N DD 43 3 5
36.2 N + - 1 N 1 39 N DD 41.8 N DD 43 N N N DD 44.2 N 3
35 N + + 2 2 2 41 N N 42 N N 43.5 N N N N 45 N N
36 N + - 1 N 1 40 N N 42.7 N N 44 N N N S 45 N 1
36 N + + 1 N 1 41.5 N N 43.5 N N 45 N N N N 46 N N
35 N + + 2 3 1 38 N N 41 N N 43 N N N N 45 N N
36 N + + 2  N 1 36.2 N N 39 N S 41 N N N S 43 N 1
35.5 1 + - 3 1 1 36 2 DD 37.5 1 DD+ 39 1 N N DD 39.2 1 4
33 N + + 1 N 1 38 N N 43 N N 44 N N N N 45.2 N N
33.3 N + + 2 N 2 38.5 N N 40 N N 42 N N N N 44 N N
34.3 N + ++ 1 1 2 39 N S 42 N DD 43.5 N N N DD 45 N 2
34.5 1 - - 2 N 1 38.5 N N 41 N N 43 N N N N 44.8 N N
33 2 + - 3 N 1 38 1 S 38.5 2 DD 39 2 N N DD 40 2 3
37.5 N + - 2 N 1 41 N N 43.5 N N 44 N N N N 45 N 1
33.6 N + + 1 N 1 39 N N 41.7 N N 42.5 N N N N 44 N N
34.6 N + + 2 N 1 38 N N 39.8 N N 41.5 N N N N 43 N N
32.5 N + - 2 1 2 38 N N 39 N S 42.5 N N N DD 44 N 1
37 N + + 2 N 2 38 N N 41.2 N N 43 N N N N 45 N N
36.5 1 + - 3 N 1 38 1 S 39 1 DD 41 1 N N DD 41.7 1 3
36 N + + 1 N 1 40 N S 42.7 N N 43 N N N N 45 N N
36 1 + - 3 1 1 38 1 DD 41 2 DD 41.8 2 N N DD 43 2 3
36.2 N + + 1 N 1 40 N N 43 N N 44 N N N N 45 N N
35 N + + 2 2 1 39 N N 42 N N 43 N N N N 44 N 1
36 N + + 1 N 2 41.5 N N 43 N N 44 N N N N 45.2 N N
36 N + + 1 N 1 40 N N 42.5 N N 43.5 N N N N 45 N N
34.7 N + + 1 2 2 39.7 N N 39.5 N N 41 N N N N 43 N N
33 1 + - 3 N 2 33.2 2 DD+ 33.5 2 DD+ 34 2 N N DD 34 2 5
35 N + + 1 N 1 39 N N 39.5 N N 41 N N N N 42.8 N N
34.6 N + - 2 N 2 38.7 N N 37.5 2 DD+ 38 2 squint + N DD 38.4 2 3
36 2 + ++ 3 1 1 40 2 S 42.6 N DD+ 43.5 2 N N DD 45 2 4
36 N + - 2 N 1 36.2 N N 39 2 N 41 N N N N 42.5 N 1
35.5 1 + - 3 1 1 36 1 DD 37 1 DD+ 38 1 N N DD 39 1 4
35 N + + 1 N 1 41 N N 43 N N 44 N N N N 45 N N
34.6 N + + 2 N 1 40 N N 42.7 N N 44 N N N N 45 N N
35.6 N + - 1 1 2 40 N S 42.8 N DD 44 N N N DD 44.7 N 2
35 N + + 1 N 1 37 N N 40 N N 42 N N N N 43.8 N 4
35 1  - - 3 2 1 40.5 2 DD 42 2 DD 43.5 2 N N DD 45 2 4
37 N  +  ++ 2 N 1 38 N N 41 N N 43.5 N N N DD 45 N 1
37 N + + 1 N 1 39 N N 41.5 N S 43 N N N N 44 N N
35 1 - - 2 1 1 39.6 1 DD 40.2 1 DD 41.5 1 N N DD 43 1 4
37 N  +  - 1 N 2 39 N DD 42 N DD 43.5 N N N S 45 N 1
36 N + + 1 N 1 40.5 N N 42 N N 43 N N N N 44.8 N N
37 N + + 1 N 2 39 N N 41.5 N N 43 N N N N 45 N N
34 N + - 1 N 2 38.8 N DD 40.5 N DD 42 N N N DD 44 N 3
34 N + + 1 3 2 38 N N 41 N N 43 N N N N 45.2 N N
35.5 N + + 1 N 1 39 N N 41 N N 43 N N N N 44.7 N N
32 N + - 2 N 1 33 N N 34 N N 36 N squint + N S 38 N 2
35 N + + 1 N 1 40 N N 42.5 N N 44 N N N N 45 N 2
38 N + + 1 N 2 40.6 N N 42 N N 46 N N N N 47 N N
35 N + - 1 N 1 38 N N 40.8 N S 41 N N N DD 42.8 N 2
34.5 N + + 1 N 1 39 N N 42 N N 44 N N N N 45 N N
34.5 N  +  + 1 N 1 37 N N 42.5 N N 44 N N N N 45 N N
33 N + + 1 N 1 38 N N 41 N N 42.8 N N N N 43.5 N N
35.5 N + + 1 N 1 40 N N 42.8 N N 44 N N N N 45.8 N N
35 N + + 1 N 1 40.5 N N 42.6 N N 44 N N N N 45.7 N N
34 N + + 1 N 1 36 N N 40 N N 42 N N N N 44 N N
A - NAME 
B – SEX 
C – GRAVIDA 
D – ANTENATAL RISK 
E – PLACE OF DELIVERY 
F- MODE OF DELIVERY 
G-RESUSCITATION 
H-NICU ADMISSION 
I – NNC 
J-VENTILATION 
K-SHOCK 
L -HYPOGLYCEMIA 
M -MULTI ORGAN INJURY 
N - SEPSIS 
O - DIAGNOSIS 
P - LENGTH 
Q - WEIGHT 
R - HC 
S - TONE 
T –NNR 
U -DTR 
V-NEUROIMAGING 
W - VISION 
X - HEARING 
Y -HC 1 (3 MONTH) 
Z -TONE 1 (3 MONTH) 
AA - DDST 1 (3 MONTH) 
AB -HC 2 (6 MONTH) 
AC - TONE 2 (6 MONTH) 
AD -DDST 2 (6 MONTH) 
AE -HC 3 (9 MONTH) 
AF- TONE 3(9 MONTH) 
AG -VISION 2 ( FOLLOW UP) 
AH -HEARING 2 ( FOLLOW UP) 
AI -DDST 3(9 MONTH) 
 AJ -HC 4 (12 MONTH) 
AK -TONE 4 (12 MONTH) 
AL -DASII 
 
 
 
 
 
 
 
KEY 
SEX   m- male, f- female 
GRAVIDA 1- primi 2- multigravida 
ANTENATAL RISK 1- meconium stained amniotic fluid 2- GDM 3-PIH 
PLACE OF DELIVERY I – inborn O - outborn 
MODE OF DELIVERY 1- normal vaginal delivery 2- assisted vaginal          
delivery 3 - lscs 
RESUSCITATION 1- tactile stimulation 2 – bag and mask ventilation           
3 - intubation 
HC ( first visit ) 
TONE N – normal 1 – hypotonia 2 - hypertonia 
NEUROIMAGING 1- normal 2- mild HIE changes 3- severe HIE 
changes 
VISION N – normal 1 – disc pallor 2- temporal pallor 3- ROP 
HEARING 1- pass 2 – refer criteria 
HC 1 (3 MONTH) 
TONE 1 (3 MONTH) N – normal 1 – hypotonia 2 - hypertonia 
DDST 1 (3 MONTH) N – normal S- suspect DD- developmental delay 
HC 2 (6 MONTH) 
TONE 2 (6 MONTH) N – normal 1 – hypotonia 2 - hypertonia 
DDST 2 (6 MONTH) N – normal S- suspect DD- developmental delay 
HC 3 (9 MONTH) 
TONE 3(9 MONTH) N – normal 1 – hypotonia 2 - hypertonia 
VISION 2 ( FOLLOW UP) N-normal 
HEARING 2 ( FOLLOW UP) N- normal 
DDST 3(9 MONTH) N – normal S- suspect DD- developmental delay 
HC 4 (12 MONTH) 
TONE 4 (12 MONTH) N – normal 1 – hypotonia 2 - hypertonia 
DASII 1 – borderline DD   2 – mild DD   3- moderate DD   4 - severe 
DD    5 - profound DD 
  
ABBREVIATIONS 
 
HIE – Hypoxic Ischemic Encephalopathy 
DASII – Developmental Assessment Scale for Indian Infants 
DDST - Denver Development Screening Tool 
VEP - Visual Evoked Potential 
BERA – Brainstem Evoked Auditory Response 
OAE - Oto Acoustic Emissions 
DQ – Development quotient 
AVD – Assisted vaginal delivery 
BMV – Bag and mask ventilation 
NNC – Neonatal convulsions 
HC – Head circumference 
AKI – Acute kidney injury 
DTR – Deep tendon reflux 
NNR - neonatal reflux 
MAS – meconium aspiration syndrome 
PIH – pregnancy induced hypertension 
GDM – Gestational diabetes mellitus 
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